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CHAPTER 1 INTRODUCTION 
Traumatic brain injury (TBI)  is a serious health problem both in the United states and 
across the globe. The Centers for Disease Control and Prevention (CDC) defined TBI 
as "an occurrence of injury to the head that can arise from blunt/penetrating trauma or 
acceleration-deceleration forces which may be associated with symptoms like 
decreased level of consciousness, amnesia, other neuropsychological abnormalities, 
intracranial lesions, or death" (Thurman et al., 1994). 
 
1.1 Epidemiology of TBI 
TBI is the leading cause of death and life-long disability in the people of the United 
States. It was estimated that each year approximately 1.5 million  Americans sustain a 
TBI (at least 3 TBIs/minute) (Sosin et al., 1995), from which, around 230,000 patients 
who seek medical attention are hospitalized (CDC, 1998). As per recent estimation, 
124,000 (43.1%) of persons discharged with TBI from acute hospitalization develop TBI-
related long-term disability (Selassie et al., 2008). Annually 51,000 Americans die from 
TBI, which accounts for one-third of all the injury related deaths (Sosin et al., 1996). In 
addition, some cases of TBI may go misdiagnosed or even unreported. An estimated 
2% of the US population, and a staggering  57 million individuals worldwide sustain TBI 
related disabilities (Ashman et al., 2006; Langlois et al., 2006). Between the years 2002 
- 2006, TBI-related emergency department visits in the United States increased by 
14.4%, hospitalizations increased by 19.5%, and deaths increased by 3.5% (Figure 1-1) 
(Faul et al., 2010). 
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Figure 1-1: Estimated number of TBI related emergency department visits, 
hospitalizations, and deaths per annum in the United States between 2002-2006. 
Adapted from (Faul et al., 2010). 
 
TBI is generally caused by a sudden, violent blow or any other traumatic injury to the 
head. The common causes of TBI include: falls, vehicle-related collisions, struck 
by/against events, assaults, non motor vehicle crashes and others (Figure 1-2) (Faul et 
al., 2010; Langlois et al., 2006). Falls result in the majority of TBI-related emergency 
department visits (523,043) and also hospitalizations (62,334) (Faul et al., 2010). Motor 
vehicle crashes are the leading cause of TBI-related deaths, with the highest rates in 
age group of 20 to 24 years (Faul et al., 2010). TBI is commonly seen in all age groups, 
but TBI rates vary by age and sex. The highest incidence of TBI is generally seen in 
children (0 to 4 years), followed by older adolescents (15 to 19 years), young adults (15 
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to 24 years) and older individuals (65 years or above) (Chua et al., 2007; Corrigan et al., 
2010). Adults aged 75 years and above are found to have the highest rate of TBI-
related hospitalization and death (Faul et al., 2010). In all age groups, TBI rates are 
higher for males compared to females, because of males risk taking tendency and 
engagements with high-risk activities (Corrigan et al., 2010; Faul et al., 2010). 
 
Figure 1-2: Estimated percentage of various causes of TBI per annum in the United 
States between 2002-2006. Adapted from (Faul et al., 2010). 
 
1.2 Burden of TBI on the Nation's Economy 
The majority of TBIs occur in young adults who are in their prime working years. TBI 
survivors, particularly those who suffered from severe TBI may not return to work from 
months to years or forever, depending on the severity of the injury and disabilities it has 
caused. As a result, TBIs tend to have a huge negative effect on the economic future of 
the country. TBI costs can be broadly divided into two categories: direct medical costs 
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for the acute treatment and indirect costs such as loss of productivity during the period 
of disability caused by TBI. It is estimated that the annual cost of TBI in the United 
States is $60.4 billion, of which productivity losses account for $51.2 billion (Finkelstein, 
2006). However, the annual loss from TBI could be much greater than the estimated 
$60.4, since the estimate is based on medical treatment alone and does not include the 
cost of rehabilitation and other services required for TBI patients with long-term 
disabilities (Corrigan et al., 2010). 
 
1.3 Rationale of the Proposed Study 
TBI is a major health concern in the United States. In spite of several extensive studies 
on developing an effective treatment for TBI, to date there are no effective 
neuroprotective therapies. One of the most common consequences observed in TBI 
patients is alterations in cerebral blood flow (CBF), because autoregulatory mechanisms 
of cerebral perfusion is often impaired following TBI. CBF is often found to be 
decreased following TBI; a reduced CBF has been associated with unfavorable 
neurological outcome and can render the brain vulnerable to secondary damage 
(delayed pathological events resulting from primary traumatic insult). Therefore, it is 
important to monitor and maintain adequate CBF following TBI. Although, several 
studies have attempted to understand the CBF changes following TBI, these studies are 
limited to only one or two anatomical regions of the brain. CBF changes in different 
regions of the brain following TBI still needs to be explored and a precise 
neuroprotective therapy needs to be developed to address deleterious alterations in 
CBF after TBI. 
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Previous studies have shown that caffeine acts as a neuroprotectant in several 
neurological disorders through various mechanisms and can play a potential role in 
altering CBF. Few studies have even demonstrated the neuroprotective effects of 
caffeine in TBI. Thus, the exact role of caffeine on CBF changes following TBI and its 
effects on outcome are still not clear. Hence, this study was undertaken to better 
understand the effects of caffeine on CBF changes following TBI in different regions of 
the brain using Arterial Spin Labeling (ASL) imaging, a magnetic resonance imaging 
(MRI) technique. The rationale of the proposed study is discussed in detail in Chapter 2. 
 
1.4 Specific Aims 
The specific aims of this study are: 
1. To determine the changes in CBF following TBI in a rat model using ASL-MRI 
imaging. 
2. To determine the effects of acute and chronic caffeine treatment on changes in 
CBF following TBI in a rat model using ASL-MRI imaging. 
3. To assess group-wise differences in CBF of rats following TBI with and without 
caffeine (chronic and acute) pretreatment. 
 
1.5 Hypothesis  
Following severe TBI, derangement of CBF often occurs, rendering the brain at risk of 
secondary damage. Caffeine may play a role to reduce the extent of such secondary 
damage by altering CBF following TBI. Acute caffeine produces vasoconstriction by 
antagonizing adenosine receptors. But chronic caffeine consumption results in an 
adaptation of the vascular adenosine receptor system and creates a tolerance to this 
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effect. It was reported that acute caffeine withdrawal from chronic caffeine ingestion 
leads to vasodilation and thus increased CBF, by binding of adenosine (Ade) to its 
receptors. It is thus hypothesized that chronic caffeine treatment prior to TBI and 
caffeine withdrawal after TBI results in favorable CBF changes post-TBI and may 
reduce the extent of secondary brain damage, potentially by optimizing CBF. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7 
 
 
CHAPTER 2 TRAUMATIC BRAIN INJURY AND CEREBRAL BLOOD FLOW 
2.1 Types of TBI  
TBI can be broadly classified into two types based on the intactness of the dura mater 
after the traumatic event. A penetrating head injury, commonly known as open head 
injury (OHI) is a head injury in which the dura matter is penetrated/pierced following TBI 
(Silver et al., 2005). Open head injury can be caused by high-velocity projectiles (e.g. a 
bullet shot from gun) as well as objects with low velocities (e.g. knives). Closed head 
injury (CHI) is defined as an injury to the head that does not penetrate the skull and the 
dura remains intact (Silver et al., 2005). CHI is caused when the head suddenly and 
violently hits an object such as in a car crash when the head strikes the dashboard. In 
general, most people think an OHI is more severe than a CHI. But a CHI can be more 
devastating than an OHI, as there is no opening to the skull and the fluids that build-up 
in the brain after CHI can increase intracranial pressure and may cause further damage. 
 
2.1.1 Closed Head Injury (CHI) 
Most common types of CHI include: concussion (temporary dysfunction of normal brain 
function), cerebral contusion (a bruise in brain tissue), diffuse axonal injury and 
intracranial hematoma. CHIs primarily occur during traffic accidents, falls, sports 
injuries, and acts of violence (CDC, 1997). Blast-related TBIs in the war-field also often 
result in CHIs to the soldiers; due to the objects dislodged by the blast which may hit the 
head severely, or people being thrown into rapid motion by the blast wave (Vasterling et 
al., 2009). From an estimated 17 million TBIs that occur annually in the United States, 
CHIs and other forms of mild TBIs account for around 75% of TBIs (Faul et al., 2010). 
CHI is the leading cause of death in children under the age of 4 years (Ibrahim et al., 
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2010). Also, it is one of major causes of physical disability and cognitive disorder in 
young adults (Cossa and Fabiani, 1999). Hence, CHIs are of greatest concern with 
regards to public health.  
 
2.1.2 Grading TBI Severity 
The grading of TBI severity from the clinical assessment  of the TBI patient is critical 
(Whitfield et al., 2009). Severity of TBI refers to the amount of acute disruption of brain 
physiology or anatomical structures following TBI (Zasler et al., 2007). The level of 
injury severity is measured using various scoring methods, such as, Abbreviated Injury 
Severity (AIS) scale, Glasgow Coma Scale (GCS), Loss of Consciousness (LOC) and 
posttraumatic amnesia (PTA). These injury scoring methods of TBI classify the injury 
severity as mild TBI (or minor TBI), moderate TBI and severe TBI (Table 1-1) (Rimel et 
al., 1982; Zuercher et al., 2009). 
 
Table 2-1: Scoring methods for grading TBI severity. Adapted and modified from PhD 
thesis (Zakaria, 2011). 
 
Classification of TBI based on injury severity 
Scoring 
Method 
Measure Mild TBI Moderate TBI 
Severe 
TBI 
AIS Anatomical/structural damage 1-2 3 4-6 
GCS Neurological deficit/mental status 13-15 9-12 3-8 
LOC Alertness/mental status < 20 min 20 min to 36 hrs > 36 hrs 
PTA Mental status/memory and recall < 24 hrs 1-7 days > 7 days 
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2.2 Effects of TBI 
TBIs can lead to massive brain damage or even death. The pathological mechanisms 
involved in neuronal cell death following TBI involve a complex interaction of acute and 
delayed anatomic, molecular, biochemical, and physiological events (Vink and Nimmo, 
2009). TBI is known to cause neurological deficits through both primary and secondary 
(delayed) events (Graham et al., 2000). Primary damage to the brain cells and tissues is 
complete at the time of impact/insult. Primary brain damage includes: skull fractures, 
contusions/bruises, hematomas, lacerations and nerve damage. Following the primary 
mechanical insult TBI results in delayed secondary brain damage due to 
neurometabolic and cellular changes that account for most of the neurological deficits 
observed after TBI. Secondary brain damage includes: hypoxia-ischemia, 
swelling/edema, raised intracranial pressure and associated vascular changes, diffuse 
axonal injury (DAI), and meningitis/abscess.  
 
Secondary damage evolves from days to years from the time of primary injury and is 
reversible (Kumar and Loane, 2012; Li et al., 2008). The development of secondary 
injury provides an opportunity for therapeutic intervention to prevent progressive 
neuronal damage and loss of function after injury. Despite several studies on 
understanding the pathological mechanisms of secondary brain damage and its 
treatment, no effective neuroprotective therapy is currently available for TBI and there is 
a growing need for therapeutic agent(s). More focused research aimed to better 
understand the poorly studied secondary injury events of TBI is very critical for the 
development of neuroprotective therapy for TBI. One such secondary injury event that is 
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poorly studied is cerebral blood flow (CBF) changes and their role in the progression of 
the secondary injury following TBI.  
 
2.3 Cerebral Blood Flow (CBF) 
CBF is defined as the arterial blood supply to the brain tissue in a given time. It is 
measured by the amount of blood supplied to a part of brain in a minute (e.g. 30 
ml/100g/min). The brain is one organ of the body which weighs only 2% of the body 
weight, but receives 15% to 18% of the total cardiac output and utilizes 20% of the total 
body oxygen and 25% of total body glucose (Zauner and Muizelaar, 1997). Brain 
requires continuous blood supply for both survival and normal functioning. The high 
metabolic demand of the brain and lack of substantial energy reserves makes it more 
vulnerable to altered CBF, as observed in most of the cerebral insults. The primary 
energy source of the brain comes from adenosine triphosphate (ATP) and other high 
energy phosphates. 
 
2.3.1 Cerebral Hemodynamics 
Normal functioning of the brain requires ample supply of oxygen and nutrients through a 
complex and dense network of blood vessels (Figure 2-1). Blood is supplied to the brain 
(also face and scalp) through two major sets of blood vessels: the right and left common 
carotid arteries and the right and left vertebral arteries. Both the carotid arteries together 
contribute approximately 80% of the total cerebral perfusion and the remaining 20% 
comes from the two vertebral arteries, which fuse to form a basilar artery (Zauner and 
Muizelaar, 1997). The carotid arteries and vertebrobasilar arteries forms a circle of 
communicating arteries at the base of the brain, known as Circle of Willis (Figure 2-2). 
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Arteries including the anterior cerebral artery, middle cerebral artery and posterior 
cerebral artery arise from the Circle of Willis and travel to other parts of brain.  
 
Figure 2-1: Figure showing the dense and complex network of arterial vessels that 
supply blood to the brain. Adapted from  (http://www.3fx.com/Our-
Work/Illustration.aspx#prettyPhoto/1/) 
 
 
 
Figure 2-2: Diagram illustrating the location of different arteries of the human brain 
(https://mynyp.org/images/my_health/ei_2397.gif). 
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In general, as the arteries travel further away from the heart, they become smaller in 
size (diameter) and are known as arterioles. They have a relatively thick and strong wall 
for their size, containing high percentage of smoothe muscle. They receive oxygenated 
blood from the arteries and supply to different parts of the brain and other organs of the 
body. Arterioles being the most highly regulated blood vessels in the body, play a 
crucial role in blood pressure regulation by the contraction and relaxation of their 
smooth muscle in the walls of the vessel. Arterioles serve to collect blood from arteries 
and deliver it to the capillaries, where important exchanges (CO2, O2, nutrients, waste, 
etc) take place. Unlike arteries and arterioles, the capillaries do not have smooth muscle 
lining surrounding them and are of single cell diameter; which aids tin fast and easy 
transfer/exchange of  gases, nutrients, wastes, etc between blood and tissue.  
 
2.3.2. Cerebral Blood Flow Regulation 
The regulation of blood flow to the brain is extremely complex as there are multiple 
overlapping mechanisms (Peterson et al., 2011). CBF is influenced and regulated by a 
number of factors, such as: intracranial pressure (ICP), arterial blood pressure (ABP), 
venous outflow, blood viscosity, partial pressure of carbon dioxide (PaCO2), partial 
pressure of oxygen (PaO2), cerebrovascular reactivity, collateral flow, and the cerebral 
autoregulation status (Zauner and Muizelaar, 1997). CBF regulation has long-been a 
topic of debate. Though a great deal of progress has been made, the interaction 
between these different components is not fully understood. However, the most 
commonly agreed regulatory mechanism involved in CBF regulation is cerebral 
pressure autoregulation. 
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2.3.3. Cerebral Pressure Autoregulation (CPA) 
The ability of the cerebral arteries (arterioles in specific) to maintain a constant CBF 
over a range of cerebral perfusion pressure (CPP) is generally defined as cerebral 
pressure autoregulation (CPA) (Peterson et al., 2011; Rangel-Castilla et al., 2008). It is 
given by the equation,  
CBF = CPP/CVR 
where, CVR = Cerebrovascular Resistance. CPP is the net driving force of the cerebral 
perfusion; it is given by the equation (Zauner and Muizelaar, 1997), 
CPP = MABP - CVP (or) CPP = MABP - ICP  
Where, MABP = Mean Arterial Blood Pressure, CVP = Cerebral Venous Pressure and 
ICP = Intracranial Pressure. 
CBF is maintained relatively constant across CPP of 50 - 150 mm Hg. In a normally 
functioning brain, only minimal CBF changes are produced within this CPP range 
(Rangel-Castilla et al., 2008). A constant CBF is maintained across this CPP range by 
an increase or decrease in vascular resistance of the vessels that supply blood to the 
brain. If CPP pressure goes beyond this autoregulation range, CBF clearly varies with 
CPP and cerebral vasodilation or vasoconstriction cannot maintain a normal CBF 
(Peterson et al., 2011). Following cerebral insult (ischemia, TBI or subarachnoid 
hemorrhage), the normal autoregulatory mechanism is lost or its range is disturbed 
(Figure 2-3) (Rangel-Castilla et al., 2008).    
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Figure 2-3: Graphs showing CPA curves in normal (A) and in TBI (B) brain (Rangel-
Castilla et al., 2008). 
 
Three main mechanisms that control cerebral autoregulatory response have been 
postulated to be metabolic regulation, myogenic regulation, and neurogenic regulation 
(Peterson et al., 2011). However, the exact mechanism controlling the autoregulatory 
response is still not clear. Metabolic regulation has been well established for more than 
a century (Roy and Sherrington, 1890). CBF varies with cerebral metabolism and the 
same was recently shown using advanced functional imaging techniques like PET or 
BOLD fMRI (Chen et al., 2001; Daly and Fredholm, 1998). Regional CBF to different 
parts of the brain is heterogeneous and is mainly determined by the cerebral 
metabolism. Normally, a tight coupling exists between the regional metabolic demand 
for energy substrates (oxygen and glucose) generated from local neuronal activity and 
the amount of blood supplied to that part of cerebral tissue. This is termed flow-
metabolism coupling (Peterson et al., 2011). However, the coupling between CBF 
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autoregulation and vasoactive metabolites is not well defined. Molecules like CO2, O2, 
K+, Ca2+, H+ and metabolites like adenosine are thought to play a role in metabolic 
coupling (Kuschinsky and Wahl, 1978).  
 
The short latency of cerebral autoregulatory response is considered to be an argument 
in favor of the myogenic mechanism (Zauner and Muizelaar, 1997). As per myogenic 
hypothesis, the smooth muscle cells (SMC) surrounding the small arteries and arterioles 
constrict or dilate in response to changes in transmural pressure (Zauner and 
Muizelaar, 1997). In an experimental study, it was found that rapid change in 
intravascular pressure alters the state of the actin and myosin filaments within the 
SMCs. Another regulatory mechanism emphasizes the extensive arborization of 
perivascular nerves to play a role in CBF regulation; this is termed neurogenic 
regulation (Zauner and Muizelaar, 1997). Most of the recent studies have predominantly 
shown the role of adenosine in the regulation of CBF (Arnaud, 1993; Fredholm et al., 
1999; Gilbert, 1984; Verbeeck, 2008) which is discussed in Section 2.5. 
 
2.4 Effects of TBI on CBF  
Cerebral autoregulatory mechanisms of blood circulation are impaired following TBI, 
which could be a critical factor in the secondary injury progression (Kennedy and 
Haskell, 2011; Sedlacik et al., 2008). It is commonly found that TBI results in reduction 
of CBF in both the clinical and experimental settings (Sedlacik et al., 2008; Shen et al., 
2007; Yuan et al., 1988). Severe TBI often results in CBF disruption that may lead to 
ischemia (inadequate blood supply) or hyperemia (excessive blood supply)  (Marion et 
al., 1991). It was proposed that cerebral ischemia is the most important cause of 
secondary brain damage after severe TBI (Marion et al., 1991). Ischemic cell changes 
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have been observed in around 90% of the patients who die following TBI (Ngai et al., 
2001). In humans, ischemic cell death is likely to occur when the CBF drops below 15 -
20 ml/100g/min. A histological study found that cerebral ischemia induced brain damage 
is common in most head-injured patients who die (Graham et al., 1978). CBF changes 
in the first few days after TBI are complex, and crucial factors like hypotension and 
hypoxia at the time of injury definitely play a crucial role on the outcome (Lobato et al., 
1988). It was also reported that global CBF was significantly reduced in TBI patients 
compared against aged matched control individuals (Barclay et al., 1985). A study on 
humans found that low CBF in the first 24 hrs after TBI was associated with poor a 
outcome, although it was not significantly different (Marion et al., 1991). Some 
experimental studies on CBF changes following CHI are discussed below. 
 
2.4.1 Experimental Studies on CBF changes following CHI 
Although CHI is the most common type of TBI, CBF changes following CHI are poorly 
understood. Several studies have attempted to determine the changes in CBF following 
a CHI (Table 2-2), but no conclusive results have been found. TBI often causes brain 
swelling resulting in the compression of ventricles (decreases CSF volume) and also 
leads to vasoconstriction (decreased blood flow) as the volume within the intact skull is 
fixed (Lunt et al., 2004). This is one of the reasons for the reductions in CBF following 
CHI, as observed in both clinical and experimental setting (Field et al., 2003; Sedlacik et 
al., 2008; Shen et al., 2007). Different experimental studies and their experimental 
model attempted to understand the CBF changes following CHI are shown below (Table 
2-2). 
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Table 2-2: Literature review on experimental studies in CBF changes following TBI. 
Reported 
by 
Weight Drop 
Model 
Specifications 
CBF 
Measured 
Using 
Regions 
Analyzed 
Post-TBI 
Time Points 
Ito et al, 
1996. 
 
SD Rats  
Height: 2 m 
Weight: 450 g 
Laser-
Doppler 
Flowmetry 
Probe in 
cerebral cortex 
30 mins to 4 hrs 
Prat et al, 
1997 
SD Rats 
Height: 1 m 
Weights: 350 g, 
400 g, 450 g 
Laser-
Doppler 
Flowmetry 
Probe in right 
frontal lobe 
Up to 8 hrs 
Petrov et 
al, 2001 
SD Rats  
Height: 2 m 
Weight: 450 g 
Laser-
Doppler 
Flowmetry 
Probe in 
cerebral cortex 
60 mins to 4 hrs 
Shen et 
al, 2007 
SD Rats 
Height: 2 m 
Weight: 450 g 
Arterial 
Spin 
Labeling 
Imaging, 
1 Slice 
L & R medial 
dorsal cortex, 
L & R 
hippocampus 
4 hrs 
24 hrs 
48 hrs 
 
Ito et al., reported a decrease in CBF in the cortex during posttraumatic hypotension 
and then a hyperemic reaction with a maximum value at 2 hours post recovery followed 
by a decreasing trend from 2 hrs to 4hrs post-TBI (Ito et al., 1996). Prat et al., reported 
a stable and normal CBF in the frontal lobe during the first three hours, followed by a 
decrease from 4 hrs to 8 hrs post-TBI, with an increase at 6 hrs post-TBI (Prat et al., 
1997). It was also found that a significant loss of autoregulation was found in 
traumatized rats compared to controls and CBF was consistently lower during this 
period (Sedlacik et al., 2008). Petrov et al, found a reduced (up to 50%) cortical 
perfusion during the second hour following TBI, but a brief increase was observed 
during the third and fourth hour and then followed by a substantial decrease at the end 
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of 4 hrs post-TBI (Petrov and Rafols, 2001). Three of the above studies reviewed here 
have used Laser-Doppler Flowmetry (LDF) for measuring the CBF which was limited to 
measurement from only one region where the probe was inserted, unlike recent studies 
that are using advanced MRI perfusion imaging techniques such as ASL which enables 
CBF measurement in multiple cerebral regions.  
 
Shen et al., have used ASL imaging technique to determine post-traumatic CBF 
changes in cortex and hippocampus (Shen et al., 2007). Medial dorsal cortex has 
shown up to a 28% reduction in CBF at 4 hrs post-TBI and some recovery at 24 hrs and 
48 hrs, but not complete recovery as compared to the baseline. Hippocampal blood flow 
also showed similar trends as in the  medial dorsal cortex, but the CBF reduction was 
only 12% at 4 hrs post-TBI (Shen et al., 2007). However, this study was done on a small 
sample size (n=5). All the four studies discussed above are limited to CBF changes only 
from one or two different anatomical regions of the brain. CBF changes in different 
regions of the brain following CHI, including the regions that are not directly under the 
impact location needs to be explored; as the impaired global CBF may affect regional 
CBF throughout the brain. Also, most of the previous experimental studies have 
analyzed CBF changes only up to 2 days post-TBI. CBF changes up to 7 days post-TBI 
needs to be studied.   
 
From the above discussion it is clear that CBF changes following TBI are extremely 
complex. However, the majority of the studies have shown a reduction in CBF at 
different post-traumatic time points and it was also mentioned before that post-traumatic 
ischemia following TBI is associated with poor prognosis. Therefore, the main aim in the 
treatment of TBI patients is prevention of secondary damage due to post-traumatic 
19 
 
 
ischemia. A study even suggested to optimize cerebral perfusion and blood flow in head 
injury treatment (Ribeiro and Sebastiao, 2010). Thus, the current study was focused on 
optimizing CBF following TBI, which may reduce the extent of secondary injury. As 
mentioned previously, adenosine and its interaction on adenosine receptors which 
influence cerebrovascular smooth muscle tone plays a crucial role in CBF regulation. 
Targeting the adenosine receptor mechanism to make favorable CBF changes, can be 
attained using a therapeutic agent (caffeine) which has structural similarity and affinity 
to adenosine. This is discussed below in detail. 
 
2.5 Adenosine and its Receptors 
Adenosine (Ade) is a purine endogenous nucleoside, present in all tissues of a 
mammalian organism and plays a central role as a structural element in nucleic acid 
energy metabolism of all living organisms (Al Moutaery et al., 2003). Ade plays a 
prominent role in biochemical processes like energy transfer (ATP - adenosine 
triphosphate, ADP - adenosine diphosphate) and in signal transduction (cAMP - cyclic 
adenosine monophosphate). It is also an inhibitory neurotransmitter, that has a role in 
promoting sleep and also in suppressing arousal; with increased levels of Ade following 
prolonged period of wakefulness. Ade is not a classical neurotransmitter produced and 
released vesicularly during axonal firing (Pelligrino et al., 2010). Low concentrations of 
Ade are usually present in the extracellular fluid, but the levels increase radically during 
enhanced neural activity, stress or in ischemic conditions by acting as a cytoprotective 
modulator (Addicott et al., 2009). Ade levels in the CNS range between 30 and 300 nM. 
Ade also acts as an extracellular signaling molecule by binding to its receptors, that  are 
virtually  found on every cell in the body (Washington et al., 2005).  
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Ade receptors belong to the family of G protein coupled receptors (GPCR), one of the 
biggest protein families with 50% of all the therapeutics targeting these receptors (Li et 
al., 2008). Four different types of Ade receptors have been characterized: A1, A2A, A2B 
and A3 (Fredholm et al., 1994). Characteristics of each of these receptors and their 
distribution in the central nervous system (CNS) is shown in Table 2-3 and Figure 2-4. It 
was found that A1 and A2A have high affinity for Ade compared to A2B and A3 receptor 
subtypes, and hence they have more physiological importance (Ribeiro and Sebastiao, 
2010). 
 
Table 2-3: Types of adenosine receptors and their distribution in the CNS. Adapted 
from (Wardas, 2002). 
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Figure 2-4: Location of different adenosine receptors in the brain 
(http://www.benbest.com/health/caffeine.html) 
 
2.5.1 Role of Adenosine in the Regulation of CBF  
Adenosine (Ade) is a potent dilator of cerebral blood vessels and was found to have an 
important role in regulation of CBF (Lusardi et al., 2012). Ade receptors on the vascular 
smooth muscle (VSM) cause vasodilation by relaxing VSM (Blaha et al., 2009; 
Washington et al., 2005). Adenosine was found to induce vasodilation when bound to 
A2A and A2B subtypes of Ade receptors (Blaha et al., 2009; Lusardi et al., 2012), by 
opening ATP-dependant K+ channels and decreasing the conductance of Ca2+; while 
other mechanisms of actions may also have a role  (Addicott et al., 2009). The half 
maximal effective concentration (EC50) values for Ade are far greater for A2A receptor 
compared to A2B receptor, suggesting that A2A receptors are likely to be of greater 
physiological importance (Nawrot et al., 2003). Though some studies indicate the role of 
A1 receptors in vasodilation, Ade acting through A2A receptor on cerebrovascular 
smooth muscle (CVSM) to induce dilation of intracerebral arterioles has been widely 
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accepted (Blaha et al., 2009; Sachse et al., 2008; Washington et al., 2005). A similar 
mechanism of vasodilation is also shown by the Ade receptors on the endothelial cells 
(Blaha et al., 2009), by releasing nitric oxide (NO) (Echeverri et al., 2010). NO derived 
from endothelial cells elicits vasodilation (Echeverri et al., 2010). It was also reported 
that Ade stimulates the production of NO in the endothelial cells, to cause vasodilation 
(Chen and Parrish, 2009; Echeverri et al., 2010). Furthermore cerebral endothelium 
may serve to regulate extracellular Ade concentrations and VSM may have a more 
complex role; Ade binds to its receptors leading to vasodilation (Johansson et al., 1997).    
 
2.6 Caffeine Consumption and Metabolism 
Caffeine (1,3,7-trimethylxanthine) (Figure 2-5) is the most popular and most highly 
consumed psychoactive drug, with an estimated 70% of the world population taking 
caffeine in some form. The majority of the Americans consume caffeine on a daily basis 
in various forms (Richard, 2005). Caffeine is present in different doses in several dietary 
sources like tea, coffee, chocolate bars, energy drinks, and others as shown in the 
Table 2-4. Coffee and tea account for about 54% and 43% of all caffeine consumption, 
respectively (Gilbert, 1984). Medicinally, caffeine is used as a stimulant, or added to 
analgesics in over the-counter formulations. It acts as a central nervous system (CNS) 
stimulant, temporarily warding off drowsiness and restoring alertness by blocking A1 and 
A2A receptors in the brain (Daly and Fredholm, 1998). 
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Figure 2-5: Chemical structure of caffeine (www.chemistry.about.com). 
 
 
Table 2-4: Caffeine concentration in various foods and beverages (Barone and Roberts, 
1996; Debry, 1994; Fredholm et al., 1999). 
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Caffeine consumption from all sources per person around the world is estimated to be 
around 70 to 76 mg/day (Gilbert, 1984). However, caffeine consumption is  much higher 
in some countries as listed in Figure 2-6, compared to the rest of the world. In the 
United States daily caffeine consumption is estimated to be around 168-220 
mg/day/person and a much higher consumption of 390–410 mg/day/person in some 
Scandinavian countries (Fredholm et al., 1999).  As per a recent market survey, the 
total number of coffee shops in the Unites States drastically increased by about 70% 
between 2000 - 2005, making a total of around 21,400 coffee houses around the 
country (http://www.marketresearchworld.net). This increasing demand for coffee may 
serve as an indirect indicator of increasing caffeine intake among Americans. Therefore, 
better understanding of caffeine mediated neuroprotection or any other potential health 
benefits is of great importance for the United States and other high caffeine consuming 
countries. 
 
Figure 2-6: Caffeine consumption (mg) per person per day in some high caffeine 
consuming countries (http://faculty.washington.edu/chudler/caff.html). 
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The consumption of moderate amounts of caffeine was found to have beneficial effects 
like increased energy availability, enhanced physical performance, increased ability to 
make correct decisions, enhanced physical and motor performance and increased 
alertness (Glade, 2010). But, when very large doses of caffeine is ingested orally, toxic 
effects are observed with a median lethal dose (LD50) of about 200mg/kg in rats 
(Eichler, 1976). LD50 of caffeine for humans (average adult) is estimated to be around 
150 to 200 mg/kg of body mass; roughly about 10 g caffeine or nearly 100 cups of 
coffee ingestion) (Fredholm et al., 1999). Daily caffeine intake was reported to be safe if 
it falls below the following limits: healthy adults (400-450 mg/kg), pregnant woman (300 
mg/kg) and children in the age group of 4-6 years (45 mg/kg) (Nawrot et al., 2003). It is 
metabolized in the liver to form several metabolites like dimethyl and 
monomethylxanthines, dimethyl and monomethyl uric acids, trimethyl- and dimethyl 
allantoin, and uracil derivatives (Arnaud, 1993) and has half-life of around 4.9 hrs to 6 
hrs in healthy adults (Verbeeck, 2008).  
 
2.6.1 Role of Caffeine in Neuroprotection against TBI 
Caffeine is both water and lipid soluble. Its hydrophobic properties makes it pass 
through all the biological membranes. This makes it readily pass through the blood-
brain-barrier (BBB) which separates the blood stream from the interior of the brain 
within 30 mins after ingestion (Fredholm et al., 1999). Any therapeutic agent against 
cerebral disorders, has to pass through the BBB to exert its effects upon drug delivery. 
Having this ability makes caffeine one of the potential therapeutic agents for the 
treatment of several neurological disorders, including TBI.  
26 
 
 
In experimental TBI, caffeine and adenosine receptor agents can be neuroprotective or 
neurotoxic, depending on the dose, model, and timing (Chen and Chern, 2011). Recent 
studies have shown that caffeine can exert a neuroprotective effect in brain injury 
models such as Parkinson’s disease, ischemic brain injury, stroke, etc (Chen et al., 
2001; Riksen et al., 2006). Few studies reported caffeine mediated neuroprotection 
against TBI through different mechanisms. In rat models, acute administration of 
extremely large doses of caffeine (100-150 mg/kg) immediately before injury worsened 
the outcome (Al Moutaery et al., 2003). On the other hand, in mice, chronic 
pretreatment with caffeine (5-50 mg/kg) reduced hippocampal neuronal cell death after 
experimental TBI (Washington et al., 2005). Similarly, other beneficial effects of chronic 
caffeine pretreatment were reported. It was demonstrated that at 24 hrs after a cortical 
impact brain injury, neurological deficits, cerebral edema, and inflammatory cell 
infiltration were all significantly attenuated in mice pretreated chronically for 3 weeks 
with caffeinated drinking water (0.1 g/L, 0.25 g/L and 5.0 g/L) (Li et al., 2008). But acute 
caffeine pretreatment (5 mg/kg, 15 mg/kg and 50 mg/kg; i.p. injection, 30 min before 
TBI,) was not effective in offering neuroprotection (Li et al., 2008) or has exacerbated 
TBI induced brain injury (Al Moutaery et al., 2003). However, acute caffeine treatment 
(i.p. injection, 20 mg/kg) 12 - 18 hrs following TBI was found to be beneficial in 
decreasing the intracranial pressure (ICP) post-trauma (Blaha et al., 2009). Dash et al., 
have reported that early administration of caffeinol (10 mg/kg caffeine plus 0.65 g/kg 
alcohol) is beneficial in reducing some of the deficits and cortical tissue loss following 
TBI using controlled cortical impact model of brain injury (Dash et al., 2004). Another 
recent study using rat fluid percussion injury found acute caffeine treatment (25 mg/kg, 
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i.p. injection within a min after impact) can prevent lethal apnea following TBI (Lusardi et 
al., 2012).  
 
 Although acute caffeine treatment following TBI is beneficial to some extent, as 
discussed earlier (Blaha et al., 2009; Lusardi et al., 2012), acute caffeine pretreatment 
adversely affects TBI outcome as evidenced by significant increase in righting latency, 
neurological deficits and mortality after closed head injury (Al Moutaery et al., 2003; Li 
et al., 2008). But, chronic treatment pretreatment provides a consistent neuroprotective 
effect following TBI as demonstrated by decreased neurological deficits, reduced 
inflammation, reduction in hippocampal neuronal cell death and modulation of glutamate 
release (Li et al., 2008; Washington et al., 2005). Also, a clinical study on humans found 
that the caffeine levels in CSF correlated with prognosis, with higher caffeine level in 
CSF predicting better clinical outcome (Sachse et al., 2008). From this discussion it is 
clear that very limited research has been done in finding the potential neuroprotective 
effects of caffeine following TBI. Substantial research has been done to understand 
both the effects of caffeine on CBF and also CBF changes following TBI, but the effects 
of caffeine on CBF changes following TBI still needs to be better understood. 
 
2.6.2 Caffeine Effects on CBF through its action on Adenosine Receptors 
Caffeine is a weak non-specific adenosine (Ade) receptor antagonist and causes most 
of its biological effects via antagonizing all types of adenosine receptors (Addicott et al., 
2009). Caffeine has structural similarity to Ade and tends to bind to Ade receptors. It 
exerts vasoconstrictive effects by antagonizing Ade receptors on vascular cells (e.g. 
smooth muscle, endothelium) (Pelligrino et al., 2010). Ade binding to the A2A and A2B 
receptor subtypes located on cerebrovascular smooth muscle causes vasodilation as 
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discussed in previously (Ngai et al., 2001). But caffeine, at normal dietary 
concentrations, acts as a competitive antagonist of A2A and A2B receptors located on 
vascular smooth muscle and prevents the vasodilatory effects of Ade (Addicott et al., 
2009). A 250 mg caffeine dose has been shown to reduce in resting CBF between 22% 
and 30% (Field et al., 2003; Lunt et al., 2004).  
 
However, evidence from receptor binding, and physiology studies suggest an 
adaptation (tolerance) to the effects of caffeine following chronic intake. This adaptation 
presumably accounts for the development of tolerance to the vasoconstrictive and 
neurostimulant effects of caffeine (Addicott et al., 2009). Some receptor binding studies 
on rodents suggest that the majority of this adaptation is due to receptor upregulation 
(e.g. increase in the number of Ade receptors) (Johansson et al., 1997) and also from 
the sensitization (e.g. conversion to high affinity state) of the Ade receptors following 
chronic caffeine intake (Green and Stiles, 1986). Tolerance to caffeine effects develops 
very quickly, especially after heavy doses, e.g. tolerance to sleep disruption (400 mg of 
caffeine 3 times a day for 7 days) and tolerance to subjective effects of caffeine (300 mg 
3 times per day for 18 days (Fredholm et al., 1999). A study reporting upregulation of 
A2A receptors on human platelets following 2 weeks of chronic caffeine treatment also 
supports this hypothesis (Varani et al., 1999). Another study on development of 
tolerance to effects of caffeine on blood pressure and heart rate also serve as an 
indirect evidence for Ade receptor upregulation following chronic intake (Denaro et al., 
1991).  
 
The withdrawal effects of chronic caffeine following a period of abstention also indicates 
the role of Ade receptors adaptation. Headache, impaired concentration, irritability, 
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drowsiness, insomnia and fatigue are commonly observed caffeine withdrawal 
symptoms that emerge from 12 to 24hrs following caffeine cessation (Fredholm et al., 
1999; Lane and Phillips-Bute, 1998; Nehlig, 1999). These effects peak at ~48 hrs, and 
usually lasting from 1 to 7 days and occasionally beyond 7 days  (Fredholm et al., 1999; 
JHU, 2003). Chronic caffeine use of even small doses (100 mg/kg) was found to result 
in withdrawal symptoms (Griffiths et al., 1990). It is very important to note that 
headaches are most commonly observed following caffeine withdrawal from chronic 
ingestion, and this corresponds with increased CBF after 20 - 24 hrs of caffeine 
abstention (Couturier et al., 1997; Jones et al., 2000). This may be due to the Ade 
binding to an increased number of Ade receptors on vascular smooth muscle which are 
normally antagonized by chronic caffeine levels in the body (Addicott et al., 2009). 
However, the extent of Ade receptor upregulation depends on the amount of caffeine 
intake per day, and therefore it is unique to every individual.  
 
2.7 Hypothesis: Chronic Caffeine mediated CBF changes following TBI 
Despite extensive research, no effective neuroprotective therapy is currently available 
for TBI. From the above discussions, it is very clear that reduction in CBF is the single 
most important secondary damage caused to the brain following TBI and it has been 
associated with unfavorable neurological outcome. Therefore, restoring CBF during the 
acute phase following TBI may improve neurological outcome. One such compound that 
can potentially play a role in such restoration is caffeine, following  chronic intake. 
Caffeine exerts its action on Ade receptor present on cerebrovascular smooth muscle. 
We hypothesize that chronic caffeine treatment prior to TBI and caffeine withdrawal 
following TBI may result in favorable CBF changes and thus reduce the extent of 
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secondary injury damage. In addition, adaptation of the Ade receptors on the 
cerebrovascular smooth muscle may also play a role in CBF restoration following TBI, in 
chronic caffeine pretreated rats. This hypothesis (Figure 2-7) if proved will serve as a 
stepping stone in CBF management following TBI.   
 
 
Figure 2-7: Demonstration of hypothesis of this study. 
 
To confirm the hypothesis that chronic caffeine pretreatment can restore CBF following 
TBI, effects of acute caffeine pretreatment on CBF following TBI also needs to be 
studied. It is hypothesized that acute caffeine pretreatment will demonstrate 
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exacerbated reduction in CBF during acute period following TBI. Therefore, unlike 
chronic caffeine pretreated rats, acute caffeine pretreated rats may not provide any 
beneficial effects on CBF following TBI. 
 
Given its widespread use, it is very important to know the status of caffeine withdrawal 
in TBI patients, before giving any drug to alter the CBF. Increased CBF as a result of 
overnight caffeine withdrawal, accompanied by any vasodilatory drug given for 
maintaining CBF may worsen the outcome by leading to hyperemia. Therefore, it is 
essential to understand the caffeine withdrawal effects following TBI to minimize 
differences in CBF in a subject sample that includes chronic caffeine consumers. 
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CHAPTER 3 CEREBRAL BLOOD FLOW MEASUREMENT USING ARTERIAL SPIN 
LABELING IMAGING 
3.1 Cerebral Blood Flow Measurement Techniques 
CBF and metabolism are highly controlled processes in a normal functioning brain, but 
they are frequently impaired following TBI and in other neurological diseases. An 
impaired CBF has been found to trigger secondary brain damage (especially in early 
phases), and consequently worsening of the patient's outcome. Therefore it is essential 
to measure and understand CBF changes following TBI, as this will enable an improved 
and more effective planning of therapeutic strategies to reduce the extent of secondary 
brain damage (Bor-Seng-Shu et al., 2012; Coles, 2006). The technologies available to 
measure CBF have evolved over time, and a number of advanced perfusion imaging 
techniques are currently available. The main imaging techniques dedicated to cerebral 
hemodynamics are positron emission tomography (PET), single photon emission 
computed tomography (SPECT), xenon-enhanced computed tomography (XeCT), 
dynamic perfusion computed tomography (PCT), MRI dynamic susceptibility contrast 
(DSC), perfusion weighted imaging (PWI), arterial spin labeling (ASL), and Doppler 
ultrasound (Wintermark et al., 2005). Although the underlying principles of each of these 
techniques are different, all these techniques provide similar information about cerebral 
hemodynamic parameters like CBF and cerebral blood volume (CBV). A comparison on 
some important aspects of some of the perfusion imaging techniques are shown in 
Table 3-1. Each technique has its own advantage and drawbacks. As part of our efforts 
to understand CBF changes following TBI we used an ASL imaging technique that is 
becoming more accessible with the availability of high field MR units (Monet et al., 
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2009). The main advantage ASL imaging is its ability to obtain repeated measurements 
of CBF, both noninvasively and rapidly. However, the clinical applications of ASL are 
still under evaluation. 
Table 3-1: Comparison of commonly used perfusion imaging techniques. Modified from 
(Wintermark et al., 2005). 
Property 
Perfusion Imaging Technique 
PET SPECT Doppler PWI ASL 
Contrast agent 
requirement 
Yes Yes No Yes No 
Data 
acquisition 
5–9 mins 10–15 mins 10–20 mins 
5-15 
mins 
5–10 mins 
Data 
processing 
5–10 mins 5 mins None 20 mins 5 mins 
Assessed 
parameters 
CBV, CBF, 
rOEF, 
glucose 
metabolism 
CBF 
Internal 
carotid artery 
BFV 
CBV, 
CBF 
CBF 
Reproducibility 5% 10% 5%  10% 
Minimal time 
interval 
between 2 
successive 
exams 
10 mins 10 mins 0 mins 30 min 0 mins 
Brain 
coverage 
Whole brain Whole brain 
One 
measurement 
for each 
hemisphere 
Whole 
brain 
Whole brain 
Spatial 
resolution 
4–6 mm 4–6 mm NA 4 mm 2 mm 
Clinical 
applications 
Dementia 
and 
psychiatric 
diseases, 
epilepsy, 
brain 
tumors, 
brain 
activation 
studies 
Trauma, 
dementia 
and 
psychiatric 
diseases, 
epilepsy, 
brain 
activation 
studies 
Trauma, 
vasospasm 
Stroke, 
ischemia 
and 
trauma 
Trauma, 
neurodegen
erative 
disorders, 
brain tumors, 
brain 
activation 
studies 
CBV=cerebral blood volume, rOEF=regional oxygen extraction fraction, BFV=blood flow 
volume. 
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3.2 Arterial Spin Labeling Imaging 
Principle of ASL: ASL is a magnetic resonance imaging (MRI) technique that provides 
highly repeatable and quantitative measures of CBF (Liu and Brown, 2007). It is 
performed non-invasively by magnetically tagging (by inverting or saturating) the water 
nuclei in arterial blood (to serve as a diffusible tracer) before it enters into the plane of 
interest in the designated tissue. Following certain transit time through this plane of 
interest, the amount of labeling is measured. This labeling is then compared to a control 
image which is obtained without spin labeling. By subtracting the labeled image from 
control image, the tagged spins are identified because of their difference in 
magnetization (Figure 3-1) (Monet et al., 2009). The intensity of the signal on the 
resulting (subtracted) image is proportional to perfusion, thus allowing the measurement 
of CBF.  
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Figure 3-1: Diagram showing the principle of ASL imaging technique. The difference 
between labeled and control images acquired is proportional to CBF. a) magnetic 
labeling of arterial blood, b) acquisition of labeled image in the plane of interest, c) no 
labeling of arterial blood, and d) acquisition of the control image in the plane of interest. 
Adapted and modified from (Monet et al., 2009). 
 
The local CBF can be related to the signal by the equation (Luh et al., 1999; Wang et 
al., 2003)  given below: 
 
Where, M = signal intensity, ΔM = difference in signal intensity between control and tag 
acquisitions, λ = blood/tissue water partition coefficient, α = inversion efficiency, TI1 = 
duration between the inversion and saturation pulses, TI2 = image acquisition starting 
time, T1a = longitudinal relaxation time of blood. At the 7T scanner, CBF values were 
obtained by assuming λ = 0.9 mL/g, α=0.95, TI1/TI1s/TI2/T1a(seconds) = 0.5/0.8/1/1.5, 
and the equilibrium magnetization M0 image was acquired. 
Features of ASL: The most important feature of ASL perfusion imaging is that, it does 
not require any contrast media like PET, SPECT, XeCT scanning. ASL uses 
endogenous water as a tracer (Wintermark et al., 2005). It takes 5-10 minutes for ASL 
image acquisition, depending on the quality of the scanner. Several pairs of label and 
control images are averaged to obtain the desired signal-to-noise ratio (SNR). ASL 
perfusion imaging is very sensitive to the movement of the subject during scanning, 
because ASL is a subtraction technique. With recent advancements , this sensitivity to 
motion is greatly reduced using motion correction algorithms (Wintermark et al., 2005). 
Recent technical advances have also helped improve the signal from ASL and its 
acquisition. Perfusion monitoring using ASL requires a high SNR, because there is only 
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1% difference between the two (label and control) image acquisitions (Wintermark et al., 
2005). 
 
3.2.1 Pulsed ASL vs Continuous ASL 
After the initial developments of ASL technique in 1992 (Detre et al., 1992; Williams et 
al., 1992), the ASL imaging modalities are classified into two categories: continuous 
ASL (CASL) and pulsed ASL (PASL), based on how the spin labeling is performed. 
Both these techniques require labeling of a certain amount of blood magnetization and 
acquisition of a control image is necessary. Also, both these techniques have their own 
advantages and limitations (Table 6). 
Table 3-2: Comparison of ASL perfusion imaging techniques. Adapted and modified 
from (Monet et al., 2009). 
PASL CASL 
Advantages Limitations Advantages Limitations 
 
Reduced 
magnetization 
transfer effects, 
shorter image 
acquisition time 
 
Sensitive to 
transit times, 
reduced coverage 
Good SNR 
 
Sensitive to transit times, 
magnetization transfer effect, 
application of a long off-resonance 
radio frequency (RF) pulse before 
image acquisition, loss of spin by 
blood water as it travels from 
labeling plane to imaging slice 
 
 
CASL imaging is based on an adiabatic inversion pulse. It uses continuous low intensity 
pulse to tag arterial blood at the neck until tissue magnetization reaches a steady state 
(Monet et al., 2009). But CASL has some limitations as mentioned in the Table 6. PASL 
can be used to improve blood flow quantification, by using  a short labeling RF pulse 5-
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20 ms radio frequency and by minimizing the imaging slice distance from the labeling 
region (Barbier et al., 2001; Martirosian et al., 2010). Since PASL is less effected by 
magnetization transfer effect, compared to CASL, it is more advantageous in clinical 
practice and is the most commonly used method (Monet et al., 2009). In this study, we 
have used PASL perfusion imaging for the relative measurement of CBF following TBI. 
 
3.2.2 Clinical Applications of ASL 
ASL perfusion imaging can be performed on any patient that can tolerate normal MRI 
scanning. However, clinical usage of ASL techniques is not as widespread as traditional 
MRI imaging. However, the utility of ASL has been demonstrated for a range of 
cerebrovascular diseases, both acute and chronic (Wintermark et al., 2005). Some 
studies on stroke and transient ischemic attack have demonstrated the feasibility of 
acquiring CBF measurements using ASL (Detre et al., 1998; Wolf et al., 2003). ASL has 
also been used for studying CBF changes in several pathological situations such as 
temporal lobe epilepsy, cerebral tumor perfusion, malignant gliomas and to evaluate   
functional brain activation. However, studies related to CBF measurement following TBI 
in animal models are limited, especially those using ASL imaging. The most important 
advantage of ASL is its ability to perform repeated measurements non-invasively, which 
is often needed before and after giving any vasoactive drug for neuroprotection through 
therapeutic intervention and also in case of neurointerventional procedures like stenting 
or  carotid endarterectomy (Wintermark et al., 2005). Most importantly, ASL CBF maps 
can help neurosurgeons in planning neuro-surgical procedures. In the recent years, 
ASL is being widely used to understand CBF changes following TBI in both clinical and 
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experimental settings (Bir et al., 2012; Hayward et al., 2011; Kim et al., 2010; Shen et 
al., 2007).  
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CHAPTER 4 TO DETERMINE CEREBRAL BLOOD FLOW CHANGES FOLLOWING 
TBI IN A RAT MODEL USING ASL-MR IMAGING (SPECIFIC AIM 1) 
4.1 Introduction 
As discussed previously (Chapter 2), several studies have attempted to understand the 
CBF changes following TBI. But, very limited information is available on the CBF 
changes in various regions (right parietal cortex, left parietal cortex, right striatum, left 
striatum, right hippocampus, left hippocampus, bilateral thalamus and brainstem) of the 
brain following TBI. Therefore, specific aim 1 of this study attempts to analyze relative 
changes in regional and global CBF following TBI, at 4hrs, 24 hrs, 3 days and 7 days 
post-TBI. 
4.1.1 Rationale for using Marmarou Impact Acceleration Model 
Various animals models of TBI are currently in use to understand the pathological 
events underlying human TBI and to develop effective therapies to reduce the extent of 
cellular damage (Cernak, 2005). These models are capable of reproducing almost all 
the injury events observed in human brain trauma. The most commonly used 
experimental models to study traumatic axonal injury (TAI), the most common 
consequence of TBI, and its implications are shown in Table 4-1. TBI induction in 
smaller animals came into existence when Marmarou and colleagues  developed a 
simple inexpensive weight-drop model using rats (Marmarou et al., 1994). Since then it 
is well known as "Marmarou head impact model" or "impact acceleration model" and 
became one of the most widely used models (Cernak, 2005; Kallakuri et al., 2012; 
Wang and Ma, 2010). The selection of this experimental model is based on the 
research goals and specific objectives of the current study. This study aims to 
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understand CBF changes (a potential contributor of secondary brain damage when CBF 
falls drastically) following CHI. It was reported that TBI induced through the Marmarou 
impact acceleration model is capable of producing both vascular and neural changes 
(Foda and Marmarou, 1994). Changes in arterial blood pressure resulting from TBI 
induced by this model may lead to vasoconstriction of cerebral vessels, leading to 
decreased CBF (Foda and Marmarou, 1994; Marmarou et al., 1994). Significant 
changes in the CBF of cortical regions following TBI induced by the weight drop model 
have already been reported (Ito et al., 1996; Petrov and Rafols, 2001; Prat et al., 1997; 
Shen et al., 2007). Therefore, the Marmarou impact acceleration model is an 
appropriate choice for both understanding CHI mediated CBF changes and for the 
development of possible therapeutic agents which can offer neuroprotection by limiting 
cellular injury potentially mediated by CBF changes. 
Table 4-1: Experimental in vivo models of TAI (Wang and Ma, 2010). 
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Injury Device 
The injury device used for this study was slightly modified from the original Marmarou 
model (Figure 4-1) in which a plexiglass tube (inner diameter 19 mm, outer diameter 25 
mm, height 2.5 m) was attached to a stand using three clamps. Rigidity of the plexiglass 
tube may not be assured when fixed to a stand as it is prone to undergo vibrations as 
the impactor falls freely. So as to improve the structural stability, we secured the 
plexiglass to a steel building column . The impactor consisted of a column of brass 
weights (50 g each) together to form a 450 g impactor (18mm diameter). A steel disc 
(helmet) (10 mm diameter) was fixed to the exposed rat skull, positioned midline 
between lambda and bregma using cyanoacrylate (Figure 4-2). This helmet prevents 
skull fractures at the site of impact  and also distributes the impact energy; but does not 
compromise in achieving high kinetic energy levels at the site of impact delivery 
(Marmarou et al., 1994). The rat was positioned in the foam bed (12x12x43 cm) under 
the plexiglass tube with the helmet centered just below the plexiglass tube. TBI will be 
induced by releasing the impactor from a height of 2 m on to the helmet. 
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Figure 4-1: Schematic representation of the Marmarou impact acceleration model. 
Adapted from (Marmarou et al., 1994).  
 
 
Figure 4-2: Demonstration of the helment placement on rat brain in sagittal view (A)  
(Kallakuri et al., 2012) and in axial view on the exposed skull, between bregma and 
lambda (B). 
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4.2 Methods  
4.2.1 Animal Handling 
All surgical and animal handling procedures were approved by the Institutional Animal 
Care and Use Committee (IACUC), Wayne State University, Detroit. A total of 16 adult 
male Sprague Daley rats (Harlan, Indianapolis, IN) weighing 350-425 g were utilized as 
a part of specific aim  1. The rats were randomly assigned into two groups: sham (n=7) 
and TBI-only (n=9). All the rats had free access to food and water.  
4.2.2. Surgical Procedures and TBI Induction 
The rats were anesthetized initially by a mixture of 3% isoflurane and 0.6L/min oxygen 
in an anesthesia chamber. After 3 mins of induction, anesthesia was maintained at 2-
3% isoflurane and 0.6L/min oxygen via a nose cone. The eyes of the animal were 
lubricated with sterile ophthalmic ointment to prevent corneal drying. The scalp and 
surrounding area was shaved with electric clippers to gain access to the surgical site. 
The skin was cleaned and disinfected alternatively with Betadine and 70% alcohol 3 
times. After ensuring that the rats were unresponsive to noxious stimulation, a midline 
skin incision of ~3cm was made exposing the periosteum covering the vertex of the 
skull. The periosteum was reflected and a 10 mm diameter steel disc with a thickness of 
3 mm was affixed using cyanoacrylate (Elmer's Products, Columbus, OH) at the midline, 
between bregma and lambdoid sutures. The rat was positioned in a prone position on a 
foam bed contained in a Plexiglas box and secured in place with tape to prevent any 
movement of the rat before the impact and to prevent falling off the foam bed after TBI. 
Just prior to the induction of TBI, the nose cone supplying anesthesia was taken off. 
Then, the 450 g cylindrical brass weight (18 mm diameter) was dropped from 2 m on to 
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the steel helmet affixed to the exposed skull. To avoid a second impact, the Plexiglas 
box was quickly removed after impact. Immediately after the impact, rats were laid on 
their back and were monitored for latency to surface right (elaborated in next 
paragraph). After surface righting, the steel helmet was removed and the skull was 
examined for any fractures. The wound was cleaned and disinfected with Betadine 
solution (1:10 dilution) and the skin was closed with sterile suture (4.0). The rats were 
returned to their cages in a supine position and allowed to recover. For sham rats, all 
surgical procedures including placement on the foam bed were performed but the rats 
were not subjected to TBI. 
4.2.3 Surface Righting Reflex 
Surface righting (SR) is the ability of an animal to roll over from a supine position (on its 
back) to prone position (Figure 4-3). It is also known as reflex righting. SR time is the 
time taken by an animal to come back to its natural normal ventral position after being 
placed on its back following head impact. TBI results in loss of consciousness from 
minutes to hours following impact, depending on the severity of the injury. Therefore, 
SR time serves as an indirect indicator of duration of unconsciousness  of rats following 
impact (Adams, 1986). 
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Figure 4-3: Diagram of a rat in supine position turning over to prone position, 
demonstrating the surface righting reflex immediately after TBI. Modified from (Yang et 
al., 2002). 
 
In this study, SR duration from all the rats in both sham and TBI rats was recorded. For 
TBI group rats, SR duration is the time taken to do surface righting following head 
impact. For sham rats, SR duration was taken as the time to surface right following 
sham surgery. 
4.2.4 Perfusion and Termination 
All the rats used in this study were sacrificed 7 days post-TBI or sham surgery 
following completion of the last MRI scanning. This study having an imaging 
component, rats were scanned several times before and after TBI. In case of sham 
rats, they were pre-scanned  twice, i.e., 21 days before water treatment and 1 day 
before sham surgery. In the case of TBI rats, they were pre-scanned only 1 day before 
TBI. Post-sham surgery or post-TBI scanning's were at 4 hrs, 24 hrs, 3 days and 7 
days (Table 4-2). 
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At the conclusion of 7 day post-TBI MRI scanning procedure, rats were anesthetized 
(50 mg/kg sodium pentobarbital) and CSF was then harvested by placing the rats in 
sternal recumbency with the chest and front legs placed over a rolled surgical towel 
(approximately 1.5 - 2 inches in diameter). CSF was collected by inserting a TB 
syringe with 26x1/2” gauge needle in the atlanto-occipital membrane and then into the 
underlying dura to reach cisterna magna.  About 50-100 µl of CSF was collected from 
each rat. Then the lateral chest wall and overlying skin was rapidly cut open with blunt 
scissors on both sides of the sternum exposing the heart. About 1.5 mL of blood was 
collected from the heart using a 25 gauge needle and was centrifuged to separate the 
serum. The serum and CSF sample were then stored at -80ºC for future biomarker 
studies. To perfuse the brain, a 22 gauge needle was introduced into aorta to perfuse 
with normal saline (100 ml). Venous return was drained by opening the right atrium, 
followed by perfusion with cold 4% paraformaldehyde in phosphate buffered saline 
(400 ml) to fix the brain. The perfused brain was harvested and post fixed in cold 4% 
paraformaldehyde with 20% sucrose for future histological assessment.  
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Table 4-2: Demonstration of the step wise procedures performed on rats from sham 
and TBI groups.  
Step wise procedure Sham group (n=7) TBI-only group (n=9) 
21 days before TBI MRI NA 
3 Weeks pure water treatment ✔ NA 
1 day before sham surgery or 
TBI 
MRI MRI 
On the day of surgery/TBI impact 
skin incision 
 (sham surgery) 
TBI impact  
(2 m height, 450 g 
weight) 
4 hrs post-TBI MRI MRI 
24 hrs post-TBI MRI MRI 
3 days post-TBI MRI MRI 
7 days post-TBI MRI MRI 
CSF, serum samples and brain 
harvest on 7th day 
✔ ✔ 
NA = not applicable and  ✔ = Performed as described in left most column. 
 
4.2.5 ASL Image Acquisition   
At the designated imaging time points, each rat was initially anesthetized in a 
anesthesia chamber by a mixture of 3% isoflurane and 0.6L/min oxygen for 3 mins. 
Anesthesia was maintained by 0.75-1.75% isoflurane and 0.6 L/min of oxygen via a 
nose cone encompassing the duration of entire imaging procedure. Rats were secured 
with stereotaxic ear bars to minimize movement during MRI scanning. The rats head 
was positioned in such a way that it is aligned at the isocenter of the magnet. 
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All MRI measurements were performed in a 7T horizontal-bore magnetic resonance 
spectrometer (Figure 4-4) (ClinScan, Bruker, Karlsruhe, Germany) with a 30 cm bore 
actively shielded gradient coil capable of producing a magnetic field of up to 290 mT/m. 
A whole-body birdcage radiofrequency (RF) coil (inner diameter, 7 cm) was used as the 
transmitter for homogeneous RF excitation, and a surface coil was used as the receiver, 
with active RF decoupling to avoid signal interference. Though only pulsed ASL 
perfusion imaging data (for measuring CBF) was required for this study, several other 
MRI sequences (T1 and T2 imaging, Susceptibility Weighted Imaging-SWI, Diffusion 
Tensor Imaging-DTI, Magnetic Resonance Spectroscopy-MRS) data were acquired for 
future analysis. The total duration of image acquisition for all sequences for a single rat 
brain at a given time point was around 2 hrs. At the conclusion of the scanning, the rat 
was placed on a water circulating heat pad to maintain adequate body temperature. 
 
Figure 4-4: An image of the 7T MRI scanner from which the MRI data in this study was 
acquired.  
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The ASL image acquisition parameters used for this study were: repetition time (TR) = 
3000 ms, echo time (TE) = 16 ms, number of slices = 8, slice thickness = 2 mm, inter-
slice gap = 0.5 mm and number of acquisitions = 51. Eight 2D coronal slice images  
covering the entire brain (Figure 4-5) were obtained for each rat at each time point. The 
field of view (FoV) was 35x28.44 mm2 with a matrix size of 128 x 104. The voxel size 
was 0.273x0.273x2 mm3. At first, the data from the brainstem region (slices 1 to 4) was 
acquired and then the grids were moved to acquire data from the cortical and 
subcortical regions (slices 5 to 8), as shown in Figure 14. The time of acquisition (TA) of 
ASL data for all slices was around 6 mins. 
 
Figure 4-5: ASL image acquisition: Slice locations from where the CBF data was 
collected. Slices 1 to 4 covered brainstem regions and slices 5 to 8 covered cortical and 
subcortical regions of the brain. 
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4.2.6 ASL Data Analysis 
ASL data was analyzed from sham group (n = 7) and TBI group (n = 6). The CBF maps 
generated by the MRI scanner were used for the measurements of CBF. The scanner 
generated maps were imported into signal processing in Nmri (SPIN) software (version 
2045), developed here at Wayne state University (http://www.mrc.wayne.edu/) for MRI 
data analysis. The imported ASL images were amplified (up to three times) for an 
accurate region of interest (ROI) delineation. The ROI around brain regions was drawn 
using the "polygon selection" in SPIN software. Brain regions were identified and 
delineated by using Paxinos rat brain atlas (Figures 15, 16 and 17) (Paxinos and 
Watson, 2007). The mean value of the signal intensity obtained from each ROI served 
as the arbitrary CBF value for that region. Since we measured only relative CBF 
changes and not the absolute CBF, the CBF mean values do not have a measurement 
unit. We measured CBF in various regions and termed these measurements as regional 
CBF (rCBF). The regions included: right parietal cortex (Rt PCx), left parietal cortex (Lt 
PCx), average of left and right parietal cortex (Avg PCx), right striatum (Rt St), left 
striatum (Lt St), average of left and right striatum (Avg St), right hippocampus (Rt Hp), 
left hippocampus (Lt Hp), average of left and right hippocampus (Avg Hp), bilateral 
thalamus (Th) and brainstem (Bs) (Figures 4-6, 4-7 and 4-8). The ROI drawn for parietal 
cortex (PCx) consisted of areas that corresponded to primary and secondary 
somatosensory cortex (Paxinos, 1985). Average CBF values from all these regions (Rt 
PCx, Lt PCx, Rt St, Lt St, Rt Hp, Lt Hp, Th and Bs) were then used to calculate a 
combined regional CBF (combined rCBF). In addition, average global CBF (gCBF) was 
also measured by drawing a single ROI around the complete brain in each of the 8 ASL 
slices. Table 4-3, shows the number of slices that were used to measure CBF for each 
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region. For each group of rats (sham and TBI) at any given time point, CBF values 
obtained from a brain region from all the rats in that group was averaged to represent a 
mean CBF value for that region. 
Table 4-3: Different brain regions from where CBF was measured and the number of 
ASL slices from which CBF were measured. 
  Brain regions where CBF was measured 
Number of ASL slices 
from which CBF was 
measured 
Right parietal cortex (Rt PCx) 2 
Left parietal cortex (Lt PCx) 2 
Average of left and right parietal cortex (Avg PCx) 2 
Right striatum (Rt St) 1 
Left striatum (Lt St) 1 
Average of left and right striatum (Avg St) 1 
Right hippocampus (Rt Hp) 1 
Left hippocampus (Lt Hp) 1 
Average of left and right hippocampus (Avg Hp) 1 
Bilateral thalamus (Th) 1 
Brainstem (Bs) 3 
Combined rCBF 5 
Global CBF 8 
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Figure 4-6: ASL image of a rat brain showing regions of interest (ROIs) for CBF 
measurement and the corresponding anatomical map  (Paxinos and Watson, 2007). 
Left parietal cortex = Lt PCx, right parietal cortex = Rt PCx, left hippocampus = Lt Hp, 
right hippocampus = Rt Hp and bilateral thalamus = Th.  
 
 
Figure 4-7: ASL image of a rat brain showing regions of interest (ROIs) for CBF 
measurement and the corresponding anatomical map  (Paxinos and Watson, 2007). 
Left parietal cortex = Lt PCx, right parietal cortex = Rt PCx, left striatum = Lt St and right 
striatum = Rt St.  
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Figure 4-8: ASL images of a rat brain showing regions of interest (ROIs) for brainstem 
(Bs) in three different slices from where CBF was measured and the corresponding 
anatomical maps (Paxinos and Watson, 2007). 
 
4.3 Statistical Analysis 
All data were analyzed for statistical significance using SPSS (version 20, Chicago, IL). 
The CBF value obtained from ASL images was expressed as the mean value ± 
standard error of the mean (SEM). The data were first tested for reliability by 
Cronbach's alpha test with a Cronbach's alpha value ≥ 0.7 being considered as reliable. 
Reliability of the data at each time point for all the rats was combined and tested (Table 
4-4). 
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Table 4-4: Cronbach's alpha reliability test values of the CBF mean values (ASL data) 
for all rats combined at each MRI scanning time point. 
Time point of ASL data 
Cronbach's alpha test 
value 
Pre-Rx 0.89 
Pre-scan 0.94 
4 hrs post-TBI 0.90 
24 hrs post-TBI 0.86 
3 Days post-TBI 0.93 
7 Days post-TBI 0.94 
 
Group-wise differences were analyzed by repeated measures analysis of variance 
(ANOVA). Data was further analyzed for within group differences by one-way ANOVA 
using Least Significant Difference (LSD) post-hoc test. A p value of <0.05 was 
considered as significant. 
 
4.4 Results (Sham and TBI-only groups) 
4.4.1 Surface Righting of Sham and TBI rats 
Rats in TBI group showed a significantly prolonged SR duration compared to sham rats 
(Figure 4-9). Compared to SR duration of 162±25 sec in sham rats, SR duration in TBI 
rats was significantly higher (p<0.05) with an average duration of 355±65 sec. 
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Figure 4-9: Plot showing mean SR duration of sham and TBI-only group rats. * 
indicates significant difference (p<0.05) in SR duration of TBI group rats compared to 
sham rats. 
 
4.4.2 CBF Changes in Sham rats 
As mentioned previously, CBF changes in sham rats were measured at various time 
points: pre-water treatment (pre-Rx), 1 day before sham surgery (pre-scan), 4 hrs, 24 
hrs, 3 days and 7 days post-sham surgery. 
 
Parietal cortex CBF changes in sham rats 
In PCx of sham rats, no apparent CBF changes were observed. No significant 
differences were observed between and within CBF values of Rt and Lt PCx until 7 days 
post-sham surgery (Figure 4-10). At 4 hour and 24 hour post-sham surgery, some 
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reduction in CBF was observed which was not significant. Furthermore, no differences 
were observed between Avg PCx and Rt and Lt PCx. 
 
Figure 4-10: Plot showing CBF changes in the right parietal cortex (Rt PCx), left 
parietal cortex (Lt PCx) and average of right and left parietal cortex (Avg PCx) of sham 
rats at various time points (pre-Rx=pre-water treatment, pre-scan=1 day before sham 
surgery, 4 hrs, 24 hrs, 3 days and 7 days post-sham surgery). 
 
Striatum CBF changes in sham rats 
In striatum of sham group rats, no apparent CBF changes were observed. In both, Lt St 
and Rt St, no significant temporal differences in CBF were observed between any time 
points (Figure 4-11). At 24 hour post-sham surgery, some insignificant reduction in CBF 
was observed in striatum. CBF of average of striatum also did not show any significant 
differences at any time point. 
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Figure 4-11: Plot showing CBF changes in the right striatum (Rt St), left striatum (Lt St) 
and average of right and left striatum (Avg St) of sham rats at various time points (pre-
Rx=pre-water treatment, pre-scan=1 day before sham surgery, 4 hrs, 24 hrs, 3 days 
and 7 days post-sham surgery). 
 
 
Hippocampus CBF changes in sham rats 
In hippocampus (left, right and average) of sham group rats, no apparent changes in 
CBF were observed (Figure 4-12). Pre-sham surgery level of CBF was maintained till 7 
days post-sham surgery with no significant changes between the time points. 
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Figure 4-12: Plot showing CBF changes in the right hippocampus (Rt Hp), left 
hippocampus (Lt Hp) and average of right and left hippocampus (Avg Hp) of sham rats 
at various time points (pre-Rx=pre-water treatment, pre-scan=1 day before sham 
surgery, 4 hrs, 24 hrs, 3 days and 7 days post-sham surgery). 
 
Bilateral thalamus and brainstem CBF changes in sham rats 
In thalamus of sham rats, there was a slight decrease in CBF at 4 hrs and 24 hrs  post-
surgery with recovery by 3 days post-surgery (Figure 4-13). Brainstem also showed a 
slight reduction in CBF at 4 hrs post-surgery, but recovered by 24 hrs post-surgery. 
However, no significant differences in CBF were found between time points for both 
thalamus and brainstem in sham group rats.   
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Figure 4-13: Plot showing CBF changes in the bilateral thalamus (Th) and brainstem 
(Bs) of sham at various time points (pre-Rx=pre-water treatment, pre-scan=1 day before 
sham surgery, 4 hrs, 24 hrs, 3 days and 7 days post-sham surgery). 
 
Combined regional CBF and global CBF changes in sham rats 
Both, the combined rCBF and global CBF levels of the sham group rats remained at the 
same levels as their respective pre-scan levels throughout the measured time points 
without any significant differences between any time points (Figure 4-14).  
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Figure 4-14: Plot showing changes in combined regional CBF (rCBF) and global CBF 
of sham rats at various time points (pre-Rx=pre-water treatment, pre-scan=1 day before 
sham surgery, 4 hrs, 24 hrs, 3 days and 7 days post-sham surgery). 
 
4.4.3 CBF Changes in TBI-only rats 
As mentioned previously, CBF changes in different brain regions (Rt PCx, Lt PCx, Rt St, 
Lt St, Rt Hp, Lt Hp, Th and Bs) following TBI were also analyzed at several time points: 
pre-scan (1 day before TBI), 4 hrs post-TBI, 24 hrs post-TBI, 3 days post-TBI and 7 
days post-TBI. 
 
Parietal cortex CBF changes in rats subjected to TBI-only 
In rats subjected to TBI alone, CBF in Rt and Lt PCx was observed to show a trend of 
an insignificant reduction by 4 hrs post-TBI (p=0.210 and 0.133 respectively) with a 
period of recovery by 24hrs and 3 days post-TBI (Figure 4-15). However, by 7 days 
post-TBI, CBF in Rt and Lt PCx significantly decreased (p=0.014 and 0.013 
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respectively) compared to their pre-TBI levels. This decrease in CBF at 7 days post-TBI 
was also significantly different from that at 24hrs and 3 days post TBI, but not from 4 hrs 
post-TBI.  Avg PCx (Rt and Lt PCx average) CBF also showed a similar trend with a 
significant reduction at 7 days post-TBI (p=0.011). 
 
Figure 4-15: Plot showing CBF changes in the right parietal cortex (Rt PCx), left 
parietal cortex (Lt PCx) and average of right and left parietal cortex (Avg PCx) in rats 
subjected to TBI. CBF was measured at various time points: pre-scan=1 day before TBI, 
4 hrs post-TBI, 24 hrs, 3 days and 7 days post-TBI. Asterisks indicate significant 
difference (p<0.05). 
 
Striatum CBF changes in rats subjected to TBI-only 
In TBI-only rats, CBF changes of both right and left striatum showed a trend similar to 
CBF changes of Avg St. CBF measurements at post-TBI time points 4 hrs, 24 hrs and 3 
days were not significantly different from pre-TBI CBF level (Figure 4-16). However 
right, left and average striatum CBF measurements decreased at 7 days post-TBI and 
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were significantly different (p=0.001 for all respectively) from their pre-TBI levels as well 
as from the rest of the time points (4 hrs, 24 hrs and 3 days post-TBI) (p<0.05). No other 
significant differences were observed. 
 
Figure 4-16: Plot showing CBF changes in the right striatum (Rt St), left striatum (Lt St) 
and average of right and left striatum (Avg St) in rats subjected to TBI. CBF was 
measured at various time points: pre-scan=1 day before TBI, 4 hrs post-TBI, 24 hrs, 3 
days and 7 days post-TBI. Asterisks indicate significant difference (p<0.05). 
 
 
Hippocampus CBF changes in rats subjected to TBI-only 
In rats subjected to TBI, a significant reduction (p<0.05)  in CBF of the hippocampus 
(left, right and average) was observed at 7 days post-TBI compared to their pre-TBI 
levels (Figure 4-17). Furthermore, CBF decreased at 7 days post-TBI in Rt Hp and Avg 
Hp was also significantly different (p<0.05) from their respective CBF values at 24 hrs 
and 3 days post-TBI. 
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Figure 4-17: Plot showing CBF changes in the right hippocampus (Rt Hp), left 
hippocampus (Lt Hp) and average of right and left hippocampus (Avg Hp) in rats 
subjected to TBI. CBF was measured at various time points: pre-scan=1 day before TBI, 
4 hrs, 24 hrs, 3 days and 7 days post-TBI. Asterisks indicate significant difference 
(p<0.05). 
 
Bilateral thalamus and brainstem CBF changes in rats subjected to TBI-only 
Thalamus CBF also showed a similar trend up to 3 days post-TBI, but at 7 days post-
TBI a decrease in CBF was observed (Figure 4-18). However, no significant changes in 
CBF of thalamus and brainstem were observed at any time point. In rats subjected to 
TBI, brainstem showed a slight decrease in CBF at 4 hrs post-TBI, recovered at 24 hrs 
post-TBI, again showed a slight decrease at 3 days post-TBI and recovery at 7 days 
post-TBI. 
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Figure 4-18: Plot showing CBF changes in the bilateral thalamus (Th) and brainstem 
(Bs) in rats subjected to TBI. CBF was measured at various time points: pre-scan=1 day 
before TBI, 4 hrs, 24 hrs, 3 days and 7 days post-TBI. Asterisks indicate significant 
difference (p<0.05). 
 
Combined regional CBF and global CBF changes in rats subjected to TBI-only 
In rats subjected to TBI, a significant reduction in combined rCBF and global CBF was 
observed at 7 days post-TBI compared to their pre-TBI levels (p<0.05), as well as to 
their 24 hrs post-TBI and 3 days post-TBI levels (Figure 4-19). Although a slight 
reduction in combined rCBF and global CBF was observed at 4 hrs post-TBI, it was not 
found to be significant. Both combined rCBF and global CBF changes showed a similar 
trend across all time points. 
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Figure 4-19: Plot showing changes in combined regional CBF (rCBF) and global CBF in 
rats subjected to TBI. CBF was measured at various time points: pre-scan=1 day before 
TBI,  4 hrs, 24 hrs, 3 days and 7 days post-TBI. Asterisks indicate significant difference 
(p<0.05). 
 
4.5 Discussion (Specific Aim 1) 
4.5.1 Surface righting (SR) Duration: Sham group Vs TBI-only group 
Loss of consciousness for a brief duration is commonly observed immediately following 
TBI. This is often indirectly measured by monitoring SR duration in rodent experimental 
studies (Adams, 1986; Li et al., 2011). In our study, TBI rats demonstrated significantly 
prolonged SR duration compared to rats that underwent sham surgery. Although rats in 
both sham and TBI groups were exposed to a similar anesthesia levels, the prolonged 
SR duration in TBI group can be attributed to TBI insult. This supports monitoring SR 
duration as an indirect indicator of loss of consciousness, a common phenomenon 
observed following TBI.  
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4.5.2 CBF Changes in Sham rats 
No significant changes in regional and global CBF following sham surgery 
In this study, CBF changes were measured in different brain regions: right parietal 
cortex (Rt PCx), left parietal cortex (Lt PCx), average of left and right parietal cortex 
(Avg PCx), right striatum (Rt St), left striatum (Lt St), average of left and right striatum 
(Avg St), right hippocampus (Rt Hp), left hippocampus (Lt Hp), average of left and right 
hippocampus (Avg Hp), bilateral thalamus (Th) and brainstem (Bs). No significant 
changes in regional and global CBF were observed before and 21 days after pure-water 
treatment. This indicates the reproducibility of the CBF measurements made using 
pulsed ASL imaging. The CBF in all these regions followed a trend of a slight 
insignificant indication of reduction at 4 and 24 hrs post-sham surgery followed by a 
trend of recovery at 3 days post-sham surgery with no significant differences in any of 
these regions. Furthermore, both combined regional and global CBF were measured to 
evaluate how accurately global CBF changes reflect regional CBF changes. Both 
combined rCBF and global CBF also showed an insignificant reduction at 4 hrs post-
sham surgery and recovered at 24 hrs post-sham surgery. From these it is clear that 
there were no significant changes in regional  and global CBF following sham surgery. 
Furthermore it also reveals that rCBF changes can be a reflection of global CBF 
changes. 
 
4.5.3 CBF Changes in TBI rats 
CBF changes following a closed head injury in an experimental model of TBI is poorly 
studied. The few available studies have  demonstrated CBF changes in cortical regions 
only for up to  4 hrs and 8 hrs post-TBI using laser-Doppler flowmetry (Ito et al., 1996; 
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Petrov and Rafols, 2001; Prat et al., 1997). Using a 450 g impactor dropped from 2m, 
Ito et al. observed a severe elevation in ICP resulting in reduced CBF (< 30% of control 
value) in cerebral cortex  2 hours post trauma (Ito et al., 1996). They have studied CBF 
changes only in cerebral cortex until 4 hrs post-TBI. Prat et al., demonstrated no change 
in frontal lobe CBF in the first 3 hours after trauma (1 m, 450 g), but was found to 
decrease from 4-8 hrs following TBI. They proposed that this decrease in CBF or 
increase in ICP 4-8 hrs following TBI is associated with loss of cerebral autoregulation 
(Prat et al., 1997). However, weight drop from 1 m height does not induce as severe 
injury as weight drop from 2 m height. Moreover, Prat et al. have studied CBF changes 
in only one region and only up to 8 hrs following TBI. Petrov et al., attempted to study 
the effect of closed head injury on microcirculation in a cortical region following trauma 
(2m, 400 g) and observed a decrease by 2-3 hrs after trauma, followed by trend towards 
normalization by 4 hrs post-TBI (Petrov and Rafols, 2001). These studies have 
analyzed CBF changes only up to 4 hours (Ito et al., 1996; Petrov and Rafols, 2001) 
and 8 hours (Prat et al., 1997) following TBI. They have measured the CBF using laser-
Doppler flowmetry, which can make only one measurement for each hemisphere. Our 
study demonstrated that CBF in the cortex and subcortical structures such as St and Hp 
showed an acute reduction of up to 19%, albeit insignificant, at 4 hrs post-TBI and 
recovery by 24 hrs post-TBI, as reported in these studies.  
 
Another study using MRI based perfusion imaging (ASL) measured CBF changes up to 
2 days post-TBI (2 m, 450 g) in two different regions (hippocampus and parietal cortex) 
(Shen et al., 2007). The authors reported reduction in hippocampal  CBF at 4 hrs (8-
14%), 24 hrs (8%) and 48 hrs post-TBI (18%) compared to their pre-TBI levels. Our 
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study also demonstrated that CBF in the hippocampus reduced by 4 hrs (19%) and 24 
hrs post-TBI (17%). Furthermore, they reported reduction if the CBF of parietal cortex 
using ASL data from one slice at 4 hrs (~26%), 24 hrs (23%) and 48 hrs post-TBI (17%) 
compared to their pre-TBI levels. But, the authors of the study did not analyze the CBF 
data statistically. Our study using ASL data from two slices, also demonstrated 
reduction in the CBF of parietal cortex at 4 hrs post-TBI (23%), but showed a temporal 
pattern of recovery at 24 hrs (only 6% reduction) and 3 days post-TBI (4% reduction) 
compared to their pre-TBI levels. But, Shen et al, measured CBF in only limited 
structures for only up to 48 hrs after trauma. However, in the current study CBF 
measurement encompassed diverse cortical, subcortical and brainstem regions 
extending up to 7 days post TBI using data from multiple ASL slices. To the best of our 
knowledge, no other experimental study has extensively measured both regional  and 
global CBF changes up to 7 days following a closed head injury induced using the 
Marmarou weight drop model. 
 
TBI induces region specific CBF changes 
Our study demonstrated a decrease in both regional and global CBF following closed 
head injury. In rat brains subjected to TBI, CBF in the cortical and subcortical regions 
such as PCx, St, Hp and Th was observed to be more affected compared to the 
brainstem region. This variation in rCBF changes between cortical and brainstem 
regions may be related to the location of the impact. CBF of Avg PCx, St and Hp 
showed an insignificant reduction (~19%) at 4 hrs post-TBI and then recovered by 24 
hrs post-TBI. But a significant reduction in cortical and subcortical regions CBF was 
69 
 
 
observed on 7 days post-TBI (~49%) compared to their pre-TBI levels, as well as to 
their 24 hrs post-TBI and 3 days post-TBI levels. But thalamus, as well as brainstem did 
not show any significant changes in CBF following TBI. Therefore cortical region CBF 
was found to be more effected following TBI induced by an impact acceleration injury 
model compared to brainstem. Although CBF in the brainstem, when analyzed 
separately, did not show significant changes until 7 days post-TBI, combined rCBF and 
global CBF changes which included brainstem showed a significant reduction by 7 days 
post-TBI. 
 
The combined regional CBF (rCBF) also showed an insignificant reduction of about 
16% compared to baseline at 4 hrs post-TBI and a significant reduction of ~44% 
compared to baseline at 7 days post-TBI. Global CBF also showed an insignificant 
reduction of about 20% compared to baseline at 4 hrs post-TBI and a significant 
reduction ~32% at 7 days post-TBI. In general, it clearly indicates reduction in both 
regional and global CBF at 4 hrs (~19%) and 7 days (~39%) after closed head injury. It 
was previously reported that reduction in CBF following TBI in the first few hours after 
injury may reach ischemic levels. In humans, ischemic (CBF 15 -20 ml/100g/min) cell 
death has been observed in 30% of all TBI cases within the first 6 hrs after injury 
(Bouma and Muizelaar, 1995) and was found to cause early death (Schroder et al., 
1996). This decreased CBF may even trigger secondary injury events. Also, cerebral 
ischemia have been observed in around 90% of the patients who die following TBI 
(Greve and Zink, 2009). However, the occurrence of ischemic cell death at 7 days post-
TBI is still not established. To the best of our knowledge, no other experimental studies 
have reported rCBF (Rt PCx, Lt PCx, Rt St, Lt St, Rt Hp, Lt Hp, Th and Bs) and global 
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CBF changes up to 7 days post-TBI following closed head injury. Ischemic cell death 
occurrence after 7 days post-TBI still needs further investigation. Our results show that 
CBF changes can take place even 7 days after severe TBI. Furthermore, this dynamic 
profile of CBF changes following TBI in different regions of the brain showed the 
existence of some regional differences in brain response to trauma, revealing the spatial 
and temporal dynamics of cerebral perfusion following TBI. 
 
 Although the reduction in regional or global CBF at 4 hrs post-TBI was not significant, it 
may still play a role in inducing injury changes. This acute drop in CBF following TBI 
may be one of the reasons for secondary (delayed) brain damage following TBI. Some 
studies even suggested prevention and early treatment to maintain CBF may lead to 
better prognosis and functional recovery following TBI (Pace et al., 2006; Ribeiro and 
Sebastiao, 2010). Impaired cerebral autoregulation may be one of the reasons for the 
abnormal CBF changes following TBI and it was suggested to be associated with 
various cerebrovascular abnormalities following  head injury (Sviri and Newell, 2010). It 
was further suggested that impaired cerebral autoregulation might increase the 
vulnerability to cerebral ischemic insult (Sviri and Newell, 2010). However, it is still not 
clear whether posttraumatic reduction in cerebral perfusion is due to intracranial 
hypertension or it was due to impaired autoregulation  mediated by the pathological 
changes in cerebral vasculature. As the volume within the intact skull is fixed, post-
traumatic inflammation leading to vasoconstriction (decreased CBF) may be one of the 
reasons for sub-acute (7 days post-TBI) reduction in CBF (Lunt et al., 2004). Therefore 
it is important to monitor, understand and maintain CBF for the long term (at least for 
one week after head injury) in TBI patients to prevent ischemic cell death or any other 
71 
 
 
secondary pathological mechanisms that may be triggered by reduced CBF. Potential 
therapeutic agents which can offer neuroprotection by making favorable CBF changes 
need to be developed. 
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CHAPTER 5 TO DETERMINE THE EFFECTS OF CHRONIC AND ACUTE CAFFEINE 
ON CEREBRAL BLOOD FLOW CHANGES FOLLOWING TBI IN A RAT MODEL 
USING ASL-MR IMAGING (SPECIFIC AIM 2) 
5.1 Introduction 
CBF regulation mediated by adenosine receptor mechanisms is often impaired following 
TBI. We observed that both regional and global CBF were found to be affected following 
TBI induced by an impact acceleration device. Considering the potential implications of 
a reduced CBF, there is a need to identify potential therapeutic agent(s) that can restore 
or maintain CBF. This, motivated us to study the role of chronic and acute caffeine in 
offering such benefit (restoration or maintenance of CBF) following TBI. Caffeine utilizes 
adenosine receptors to exert its effects on CBF and thus specific aim 2 of this study 
attempts to analyze relative changes in regional and global CBF following TBI in rats 
pretreated with chronic and acute caffeine. 
 
5.2 Methods 
5.2.1 Animal Handling 
All surgical and animal handling procedures were approved by the Institutional Animal 
Care and Use Committee (IACUC), Wayne State University, Detroit. A total of 17 adult 
male Sprague Daley rats (Harlan, Indianapolis, IN) weighing 350-400 g were utilized as 
a part of specific aim 2. Rats were randomly assigned to two pretreatment groups: 
chronic caffeine+TBI (CC+TBI) (n=9) and acute caffeine+TBI (AC+TBI) (n=8). All the 
rats had free access to food.   
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5.2.2 Caffeine Treatment 
For chronic caffeine pretreatment, rats were  given drinking water mixed with caffeine 
(caffeinated water) (1.5 g/L, caffeine cat# C0750, Sigma Aldrich, St. Louis, MO) for 
three weeks before TBI and acute caffeine treatment rats were given a single dose of 
caffeine (150 mg/kg) 30 mins before TBI. During caffeine pretreatment, rats were 
housed individually with their own water bottle for 3 weeks after which they were 
subjected to TBI. Following TBI, they were given regular water with no caffeine.  
AC+TBI group rats had free access to regular drinking water throughout. Caffeinated 
water was prepared by adding caffeine to purified drinking water, and mixed for 4 mins 
using magnetic stir bar to avoid formation of lumps and ensuring that all caffeine 
dissolved completely. Caffeinated water was changed three times a week to maintain 
an appropriate caffeine concentration. The amount of caffeinated water consumed by 
each rat was monitored by measuring the caffeinated water left in the bottle before 
giving known volume of fresh caffeinated water, when changing the caffeinated water. 
Table 11, briefly demonstrates the step wise procedures performed on rats from both 
the groups. 
Table 5-1: Demonstration of the step-wise procedures performed in rats from chronic 
caffeine+TBI and acute caffeine+TBI groups. 
Step Wise Procedure Chronic Caffeine+TBI Acute Caffeine+TBI 
21 days before TBI induction MRI NA 
Caffeinated water (1.5 g/L) 
treatment for 3 weeks (no 
treatment after TBI) 
✔ NA 
1 day before TBI MRI MRI 
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Caffeine (150 mg/kg) i.p. 
injection, 30 mins before TBI 
NA ✔ 
On the day of TBI induction 
TBI impact  
(2 m height, 450 g 
weight) 
TBI impact  
(2 m height, 450 g 
weight) 
4 hrs post-TBI MRI MRI 
24 hrs post-TBI MRI MRI 
3 days post-TBI MRI MRI 
7 days post-TBI MRI MRI 
CSF, serum samples and brain 
harvest on 7th day 
✔ ✔ 
NA = not applicable and ✔ = Performed as described in left most column. 
 
5.2.3 Surgical Procedures and TBI Induction 
All surgical and animal handling procedures followed for these two groups (CC+TBI and 
AC+TBI) were similar to surgical procedures followed for the TBI-only group as 
discussed in Chapter 4 (section 4.2.1 and 4.2.2). TBI was induced by the Marmarou 
impact acceleration injury device as described before for TBI-only group in Chapter 4 
(section 4.1.1). The only difference between TBI-only group and these groups (CC+TBI 
and AC+TBI) is: chronic caffeine treated rats underwent 3 weeks of caffeine 
pretreatment before TBI induction and acute caffeine rats were pretreated with a single 
dose of caffeine 30 mins before TBI. 
 
5.2.4 Surface Righting Reflex 
SR duration for all the rats from CC+TBI and AC+TBI groups was recorded immediately 
after TBI induction in the manner described previously in Chapter 4 (section 4.2.3). 
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5.2.5 ASL Image Acquisition 
CBF changes were measured using arterial spin labeling (ASL) perfusion imaging with 
same image acquisition parameters as described in Chapter 4 (section 4.2.5). For 
chronic caffeine treated rats, ASL images were acquired at time points: pre-Rx (pre-
caffeine treatment, 21 days before TBI), pre-scan (1 day before TBI), 4 hrs, 24 hrs, 3 
days and 7 days post-TBI. For acute caffeine treated rats, ASL images were acquired at 
time points: pre-scan (1 day before TBI), 4 hrs, 24 hrs, 3 days and 7 days post-TBI. 
 
5.2.6 ASL Data Analysis 
For specific aim 2, ASL data was analyzed from 13 rats (CC+TBI group = 6 and AC+TBI 
group = 7) by drawing regions of interest (ROIs) using SPIN software as explained  in 
Chapter 4 (section 4.2.6). CBF changes were  measured in different brain regions: right 
parietal cortex (Rt PCx), left parietal cortex (Lt PCx), average of left and right parietal 
cortex (Avg PCx), right striatum (Rt St), left striatum (Lt St), average of left and right 
striatum (Avg St), right hippocampus (Rt Hp), left hippocampus (Lt Hp), average of left 
and right hippocampus (Avg Hp), bilateral thalamus (Th) and brainstem (Bs) (Figures ). 
Also, combined regional CBF (rCBF) and global CBF were measured in a similar 
method as described  in Chapter 4 (4.2.6). 
 
5.3 Statistical Analysis 
All data were analyzed for statistical significance using SPSS (version 20, Chicago, IL). 
The CBF value obtained from ASL images was expressed as the mean value ± 
standard error of the mean (SEM). The data were first tested for reliability by 
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Cronbach's alpha test (Table 10). Group-wise differences were analyzed by repeated 
measures of analysis of variance (ANOVA) (Chapter 6). Data was further analyzed for 
within group differences by one-way ANOVA using Least Significant Difference (LSD) 
post-hoc test. A p value of <0.05 was considered as significant. 
 
5.4 Results (CC+TBI and AC+TBI groups) 
Following chronic caffeine pretreatment (1.5 g/L) for 21 days or after acute caffeine 
pretreatment 30 mins before TBI, rats did not exhibit any abnormal behavior. However 
following TBI, one acute caffeine pretreated rat that exhibited severe distress was 
sacrificed 2 hrs post-trauma.  
 
5.4.1 Surface righting of chronic and acute caffeine pretreated rats in comparison 
to sham and TBI-only rats 
Rats in TBI group showed a significantly prolonged SR duration compared to sham rats. 
Compared to SR duration of 162±25 sec in sham rats, SR duration in TBI rats was 
significantly higher (p=0.004) with an average duration of 355±65 sec (Figure 5-1). 
Average SR duration in chronic caffeine pretreated rats was 269±24 sec compared to a 
surface righting duration of 309±36 sec in acute caffeine pretreated rats. Acute caffeine 
pretreated rats showed prolonged surface righting duration compared to chronic 
caffeine pretreated rats, but not at a level of significance. However, acute caffeine 
pretreated rats took significantly increased (p=0.030) SR duration (309±36 sec) 
compared to sham rats. No other significant differences were observed. 
 
77 
 
 
 
Figure 5-1: Plot showing mean SR duration of rats in different groups: sham, TBI-only, 
CC+TBI and AC+TBI groups. * indicates significant difference (p<0.05). 
 
5.4.2 CBF Changes following TBI in chronic caffeine pretreated rats 
CBF changes in CC+TBI rats were measured at several time points: pre-Rx (pre-
caffeine treatment, 21 days before TBI), pre-scan (1 day before TBI), 4 hrs, 24 hrs, 3 
days and 7 days post-TBI. 
Parietal cortex CBF changes following TBI in chronic caffeine+TBI group rats 
CBF in the parietal cortex (PCx) showed an insignificant increase at pre-scan (1 day 
before TBI), compared to pre-Rx (pre-caffeine treatment) levels (Figure 5-2). A slight 
drop in PCx CBF was observed at 4 hrs post-TBI with a trend of recovery at 24 hrs post-
TBI which again showed a trend of reduction by 3 days post-TBI. All these alterations 
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were not statistically significant compared to their pre-Rx or pre-TBI levels. By 7 days 
post-TBI, the CBF levels reached pre-scan levels. However, no significant differences 
were found in right, left and Avg PCx between any time points.   
 
Figure 5-2: Plot showing CBF changes in the right parietal cortex (Rt PCx), left parietal 
cortex (Lt PCx) and average of right and left parietal cortex (Avg PCx) following TBI in 
chronic caffeine pretreated rats at various time points:  pre-Rx=pre-caffeine treatment 
21 days before TBI, pre-scan=1 day before TBI, 4 hrs, 24 hrs, 3 days and 7 days post-
TBI. 
 
Striatum CBF changes following TBI in chronic caffeine+TBI group rats 
Similar to PCx, striatum also showed an insignificant increase in CBF at pre-scan 
compared to their pre-caffeine treatment levels. CBF of right, left and Avg St continued 
to increase at 4 hrs and 24 hrs post-TBI albeit without any significance (Figure 5-3). But, 
by 3 days post-TBI,  CBF in  Lt St was significantly decreased compared to 24 hrs post-
TBI level (p=0.026); and by 7 days post-TBI, the CBF significantly recovered compared 
to its 3 days post-TBI level (p=0.040). Avg St also showed a trend similar to Lt St. No 
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significant CBF changes were observed in right striatum. Left, right and Avg St did not 
show any significant changes in CBF compared to pre-Rx or pre-scan levels. 
 
Figure 5-3: Plot showing CBF changes in the right striatum (Rt St), left striatum (Lt St) 
and average of right and left striatum (Avg St) following TBI in chronic caffeine 
pretreated rats at various time points: pre-Rx=pre-caffeine treatment 21 days before 
TBI, pre-scan=1 day before TBI, 4 hrs, 24 hrs, 3 days and 7 days post-TBI. Asterisks 
indicate significant difference (p<0.05). 
 
Hippocampus CBF changes following TBI in chronic caffeine+TBI group rats 
Rt Hp, Lt Hp and Avg Hp showed a similar trend of decreased CBF at 3 days post-TBI, 
compared to their pre-scan levels; but only Rt Hp and Avg Hp  showed significant 
differences (p=0.017 and 0.036, respectively) compared to their pre-scan levels (Figure 
5-4). At 7 days post-TBI, Rt Hp and Avg Hp have showed significant increases (p=0.022 
and 0.048, respectively) in CBF compared to their 3 days post-TBI levels. No significant 
differences were observed in Lt Hp.  
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Figure 5-4: Plot showing CBF changes in the right hippocampus (Rt Hp), left 
hippocampus (Lt Hp) and average of right and left hippocampus (Avg Hp) following TBI 
in chronic caffeine pretreated rats at various time points: pre-Rx=pre-caffeine treatment 
21 days before TBI, pre-scan=1 day before TBI, 4 hrs, 24 hrs, 3 days and 7 days post-
TBI. Asterisks indicate significant difference (p<0.05). 
 
Bilateral thalamus and brainstem CBF changes following TBI in chronic 
caffeine+TBI group rats 
CBF of both bilateral thalamus and brainstem at pre-scan (21 days after chronic 
caffeine treatment) remained the same as their pre-caffeine treatment levels (Figure 5-
5). Brainstem showed a slight reduction in CBF at 24 hrs post-TBI and a temporal 
pattern of recovery at 3 days and 7 days post-TBI. However, these were not found to be 
significantly different (p<0.05). Similar to sham group rats or TBI-only group rats, both 
bilateral thalamus and brainstem of chronic caffeine pretreated did not demonstrate any 
apparent changes in CBF between any time points. 
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Figure 5-5: Plot showing CBF changes in the bilateral thalamus (Th) and brainstem 
(Bs) following TBI in chronic caffeine pretreated rats at various time points: pre-Rx=pre-
caffeine treatment 21 days before TBI, pre-scan=1 day before TBI, pre-scan (1 day 
before TBI), 4 hrs, 24 hrs, 3 days and 7 days post-TBI. 
 
Combined regional CBF and global CBF changes following TBI in chronic 
caffeine+TBI group rats 
Both the combined regional CBF (rCBF) and the global CBF followed a similar trend. 
They did not show any significant differences in CBF compared to their pre-Rx or pre-
scan levels (Figure 5-6). But at 3 days post-TBI, combined rCBF was significantly lower 
(p=0.017) compared to 7 day post-TBI levels, and global CBF showed almost significant 
reduction (p=0.062) compared to its 7 day post-TBI level. No other significant changes 
in combined rCBF and global CBF were observed in rats pretreated with chronic 
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caffeine.
 
Figure 5-6: Plot showing changes in combined regional CBF (rCBF) and global CBF in 
chronic caffeine pretreated rats at various time points: pre-Rx=pre-caffeine treatment 21 
days before TBI, pre-scan=1 day before TBI, 4 hrs, 24 hrs, 3 days and 7 days post-TBI. 
Asterisks indicate significant difference (p<0.05) in combined rCBF at 3 days post-TBI 
compared to 7 days post-TBI.  
 
5.4.3 CBF Changes following TBI in acute caffeine pretreated rats 
CBF changes following TBI in acute caffeine pretreated rats (AC+TBI rats) were 
measured at several time points: 1 day before TBI (pre-scan), 4 hrs, 24 hrs, 3 days and 
7 days post-TBI. 
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Parietal cortex CBF changes following TBI in acute caffeine+TBI group rats 
Lt, Rt and Avg PCx of acute caffeine pretreated rats following TBI showed an 
insignificant reduction in CBF by 4 hrs post-TBI compared to their pre-scan levels 
(Figure 5-7). However, a significant reduction (p=0.050) in CBF was observed at 4 hrs 
post-TBI in Rt PCx (p=0.050) compared to its 7 day post-TBI levels. Avg PCx showed 
nearly significant (p=0.066) reduction in CBF at 4 hrs post-TBI compared to its 7 day 
post-TBI level. After 4 hrs post-TBI, CBF in the PCx was found to show a temporal 
pattern of recovery with an insignificant increase by 7 days post-TBI compared to their 
pre-TBI levels. No significant differences in CBF were observed in Lt PCx and Avg PCx 
following TBI between any time points. 
 
Figure 5-7: Plot showing CBF changes in the right parietal cortex (Rt PCx), left parietal 
cortex (Lt PCx) and average of right and left parietal cortex (Avg PCx) following TBI in 
acute caffeine pretreated rats at various time points:  pre-scan=1 day before TBI, 4 hrs, 
24 hrs, 3 days and 7 days post-TBI. Asterisks indicate significant difference (p<0.05). 
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Striatum CBF changes following TBI in acute caffeine+TBI group rats 
CBF changes following TBI in striatum of the acute caffeine pretreated rats also showed 
a trend similar to that in parietal cortex. In acute caffeine pretreated rats following TBI, 
CBF in the Lt, Rt and Avg St showed an insignificant reduction by 4 hrs post-TBI 
compared to its pre-scan levels (Figure 5-8). But, a significant reduction in CBF was 
observed at 4 hrs post-TBI in Rt St and Avg St (p=0.033 and 0.039 respectively) 
compared to their 7 day post-TBI levels. No significant differences were observed in Lt 
St CBF following TBI between any time points. After 4 hrs post-TBI, a temporal pattern 
of recovery in CBF was observed at 24 hrs, 3 days and 7 days post-TBI. 
 
Figure 5-8: Plot showing CBF changes in the right striatum (Rt St), left striatum (Lt St) 
and average of right and left striatum (Avg St) following TBI in acute caffeine pretreated 
rats at various time points:  pre-scan=1 day before TBI, 4 hrs, 24 hrs, 3 days and 7 days 
post-TBI. Asterisks indicate significant difference (p<0.05). 
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Hippocampus CBF changes following TBI in acute caffeine+TBI group rats 
In acute caffeine pretreated rats subjected to TBI, significant reduction (p=0.042) in CBF 
of the left hippocampus was observed at 4 hrs post-TBI compared to its pre-scan (pre-
TBI) level (Figure 5-9). Furthermore, Lt Hp CBF at 4 hrs post-TBI showed a significant 
reduction compared to its 3 days (p=0.012) and 7 days post-TBI (p=0.019). Also, CBF 
of the Avg Hp showed a significant decrease by 4 hrs post-TBI compared to its 3 days 
(p=0.027) and 7 days post-TBI (p=0.037). CBF in the Rt, Lt and Avg Hp of acute 
caffeine pretreated rats showed a complete recovery by 3 days and 7 days post-TBI. In 
Rt Hp, no significant differences in CBF following were observed between any time 
points. 
 
Figure 5-9: Plot showing CBF changes in the right hippocampus (Rt Hp), left 
hippocampus (Lt Hp) and average of right and left hippocampus (Avg Hp) following TBI 
in acute caffeine pretreated rats at various time points:  pre-scan=1 day before TBI, 4 
hrs, 24 hrs, 3 days and 7 days post-TBI. Asterisks indicate significant difference 
(p<0.05). 
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Bilateral thalamus and brainstem CBF changes following TBI in acute 
caffeine+TBI group rats 
Unlike sham, TBI-only and CC+TBI groups, significant differences (p<0.05) in CBF of 
the bilateral thalamus (Th) and brainstem (Bs) were observed (Figure 5-10). The trends 
in CBF of Th and Bs were similar to TBI-only rats. Although Th did not show any 
significant changes in CBF following TBI compared to its pre-scan (pre-TBI) level, CBF 
at 3 days post-TBI was significantly higher from its 4 hrs post-TBI level. CBF in the Bs 
was observed to be significantly increased at 7 days post-TBI compared to its pre-TBI 
(p=0.018), 4 hrs (p=0.001) and 3 days post-TBI (p=0.019) levels.   
 
Figure 5-10: Plot showing CBF changes in the bilateral thalamus (Th) and brainstem 
(Bs) following TBI in acute caffeine pretreated rats at various time points:  pre-scan=1 
day before TBI, 4 hrs, 24 hrs, 3 days and 7 days post-TBI. Asterisks indicate significant 
difference (p<0.05). 
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Combined regional CBF and global CBF changes following TBI in AC+TBI group 
rats 
Both the combined regional CBF (rCBF) and the global CBF followed a similar trend of 
reduction by 4 hrs post-TBI and temporal pattern of recovery at 24 hrs, 3 days and 7 
days post-TBI (Figure 5-11). However, significant reduction (p=0.010) at 4hrs post-TBI 
was observed only in global CBF.  Additionally, this reduction at 4 hrs post-TBI was also 
found to be significant compared to rest of the post-TBI time points (24 hrs, p= 0.020; 3 
days, p= 0.014; and 7 days, p=0.031). Although the reduction in combined rCBF at 4 
hrs post-TBI was not significant different from its pre-TBI levels, it was found to be 
significantly reduced compared to 3 days (p=0.033) and 7 days post-TBI (p=0.020). 
 
Figure 5-11: Plot showing changes in combined regional CBF (rCBF) and global CBF in 
acute caffeine pretreated rats at various time points:  pre-scan=1 day before TBI, 4 hrs, 
24 hrs, 3 days and 7 days post-TBI. Asterisks indicate significant difference (p<0.05). 
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5.5 Discussion (Specific Aim 2) 
5.5.1 Surface righting (SR) duration: Chronic caffeine pretreated rats exhibited the 
least SR duration among the rats that underwent TBI 
As mentioned before (section 4.2.3), loss of consciousness for a brief duration is 
commonly observed immediately following TBI, which is often indirectly measured by 
monitoring SR duration. Although rats in all four groups were exposed to a similar 
anesthesia levels during surgical procedures, the rats in three groups that underwent 
TBI (TBI-only, CC+TBI and AC+TBI)  had prolonged SR duration compared to rats that 
underwent sham surgery; this can be attributed to TBI insult. However, only TBI and 
AC+TBI rats exhibited significantly higher (p<0.05) SR duration compared to sham rats. 
Although not significant, AC+TBI rats had slightly decreased SR duration compared to 
TBI rats. This can be attributed to acute caffeine pretreatment 30 mins before TBI. 
Among the rats that underwent TBI, the least SR duration was observed in chronic 
caffeine pretreated rats. Additionally, this group did not show a significant increase in 
SR duration (like TBI rats) when compared to sham rats; this can be attributed to 
chronic caffeine pretreatment before TBI. Since loss of consciousness following TBI is 
often used as a measure in grading injury severity, it may proposed that chronic caffeine 
offers potential neuroprotection  (as evidenced by decreased duration of loss of 
consciousness). To conclude, chronic caffeine pretreatment was found to be more 
beneficial compared to acute caffeine pretreatment in decreasing the duration of loss of 
consciousness immediately after TBI. 
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5.5.2 CBF changes following TBI in chronic caffeine pretreated rats 
Tolerance to vasoconstrictive effects of caffeine following chronic consumption 
in rats 
Caffeine is well known for its vasoconstrictive effects (decreased CBF) following acute 
intake. However, it was reported that chronic caffeine consumption results in an 
adaptation of the adenosine (Ade) receptors, including vascular Ade receptors and 
creates a tolerance to its vasoconstrictive effect (Echeverri et al., 2010; Johansson et 
al., 1997; Li et al., 2008). Results of our study also support potential tolerance to 
caffeine mediated cerebral vasoconstriction in rats following chronic ingestion of 
caffeinated drinking (1.5 g/L) water for 3 weeks. Both regional (PCx, St, Hp, Th and Bs) 
and global CBF levels 21 days after chronic caffeine treatment (pre-scan time point) did 
not show any significant reduction (p<0.05) compared to their pre-caffeine treatment 
levels (pre-Rx time point). Instead, there was an insignificant increase in both cortical 
PCx) subcortical  (St, Hp, Th) regional CBF and also global CBF. To summarize, no 
significant changes in regional or global CBF were observed 21 days after chronic 
caffeine treatment in rats, supporting the development of tolerance to vasoconstrictive 
effects of caffeine. 
 
Restoration of regional and global CBF following TBI in chronic caffeine 
pretreated rats 
Previous studies have reported the neuroprotective effects of caffeine against TBI 
through diverse mechanisms (Section 2.6.1). But none of the previous studies have 
reported caffeine mediated CBF changes following TBI. Our study demonstrated that 
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chronic caffeine (1.5 g/L) can potentially interfere with decreased CBF (secondary brain 
damage event) following TBI and restore CBF. Unlike TBI-only rats, CBF in the PCx and 
St of CC+TBI rats did not show any significant changes following TBI compared to their 
pre-Rx and pre-scan levels, except Hp, which showed a significant reduction (18%) by 3 
days post-TBI compared to its pre-scan level. This clearly indicates that the significant 
reduction in CBF of PCx, St, Th observed in TBI-only rats is not seen in chronic caffeine 
pretreated rats, indicating the potential role of chronic caffeine in restoring CBF 
following TBI. 
 
Similar to sham and TBI-only rats, CBF in the bilateral thalamus and brainstem of 
chronic caffeine pretreated rats also did not show any significant changes in CBF 
following TBI. It implies that chronic caffeine only restored CBF of the regions that were 
affected following TBI, but did not worsen the CBF of the regions which were not 
affected by TBI-only. Similar to sham rats, combined rCBF and global CBF did not show 
any significant changes in CBF following TBI compared to their pre-Rx and pre-scan 
levels; whereas TBI-only rats showed an insignificant reduction by 4 hrs post-TBI 
(~18%)  and a significant reduction at 7 days post-TBI (~37%). This restoration of CBF 
in the chronic caffeine pretreated rats following TBI may be attributed to adaptation of 
adenosine receptors on vascular smooth muscle cells following chronic caffeine 
pretreatment or caffeine withdrawal effect (increased CBF) after TBI. 
 
Caffeine withdrawal from chronic ingestion corresponds with increased CBF after 20 - 
24 hrs of caffeine abstention (Couturier et al., 1997; Jones et al., 2000) and caffeine 
withdrawal effects lasts from 1 to 7 days (Fredholm et al., 1999; JHU, 2003) (Discussed 
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in Chapter 2). It was also reported that in the absence of caffeine, Ade binds to an 
increased number of Ade receptors on vascular smooth muscle which are normally 
antagonized by chronic caffeine levels in the body (Addicott et al., 2009), resulting in 
increased CBF. However, it is not known when the CC+TBI rats drank caffeinated water 
for the last time before TBI and whether this CBF restoration following TBI is due to 
withdrawal effects from chronic caffeine. To the best of our knowledge, no research has 
been done previously to study withdrawal effects (increased CBF) of chronic caffeine 
following TBI. To conclude, our data demonstrating the CBF restoration following TBI in 
chronic caffeine pretreated rats supports the hypothesis that withdrawal effects 
(increased CBF) of chronic caffeine may be observed even after TBI. 
 
Furthermore, as mentioned previously in Chapter 2 (section 2.4.1), TBI often causes 
brain swelling (inflammation) resulting in the compression of ventricles and also 
constriction of cerebral blood vessels (decreased CBF), as the volume within the intact 
skull is fixed (Lunt et al., 2004). However, chronic (and also acute to some extent) 
caffeine pretreatment was reported to offer neuroprotection mediated by a decrease in 
inflammation following TBI (Li et al., 2008). Using CD45 antibody (marker of 
inflammatory cells), Li et al., showed significant reduction in CD45-positive cells 24 hrs 
after injury in chronic caffeine pretreated mice. This decreased cerebral inflammation 
following TBI in chronic caffeine treated rats may be one of the reasons in restoring the 
CBF that once reduced due to constriction of cerebral vessels due to inflammation. 
However, we have not yet studied cerebral inflammatory response following TBI in our 
study. 
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5.5.3 Acute reduction in CBF following TBI in rats pretreated with acute caffeine 
Although previous studies using different pathological mechanisms have reported that 
acute caffeine pretreatment is not neuroprotective against TBI (Al Moutaery et al., 2003; 
Li et al., 2008) as discussed under section 2.6.1, we studied the effects of a single dose 
of acute caffeine (150 mg/kg) on CBF changes following TBI. Acute caffeine is well 
known for its vasoconstrictive effects mediated by antagonizing Ade receptors on 
vascular cells (Pelligrino et al., 2010). Unlike CC+TBI rats, acute caffeine pretreatment 
30 mins before TBI showed substantial  reduction in both regional and global CBF at 4 
hrs post-TBI, but these were not significantly different. CBF in the cortical (PCx) and 
subcortical (St, Hp and Th) regions  of both TBI-only rats and AC+TBI rats showed an 
insignificant reduction up to 19% and 27% respectively, by 4 hrs post-TBI. But, in 
contrast to TBI rats, global CBF in acute caffeine pretreated rats was observed to be 
significantly reduced at 4hrs post-TBI compared to its pre-scan levels. This marked 
reduction in both regional and global CBF by 4 hrs post-TBI in acute caffeine treated 
rats compared to TBI-only rats can be attributed to the combined effect of TBI and 
vasoconstrictive effects of acute caffeine. Acute reduction in CBF following TBI may 
reach ischemic levels and worsen the outcome (Ngai et al., 2001). As mentioned earlier 
under section 2.4, a study even suggested optimization of CBF in head injury treatment 
(Ribeiro and Sebastiao, 2010). Therefore, this acute reduction (~27%) in CBF following 
TBI may worsen the outcome. Unlike sham, TBI-only and CC+TBI rats, CBF in the 
brainstem region also reduced significantly at 4hrs (22%) and 7 days post-TBI (~23%) 
compared to its pre-TBI levels. The thalamus did not show any significant changes in 
CBF following TBI in AC+TBI rats. 
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In acute caffeine pretreated rats following TBI, CBF in the cortical and subcortical 
regions (PCx, St, Hp and Th) and global CBF showed a trend towards normalization 
following reduction at 4 hrs post-TBI. TBI rats have showed significant reduction in 
regional and global CBF at 7 days post-TBI. In contrast, acute caffeine pretreated rats 
showed a complete recovery in CBF by 3 days and 7 days post-TBI. This trend of CBF 
restoration at 3 days and 7 days post-TBI may be attributed to significant decrease in 
inflammation mediated by acute caffeine treatment 24 hrs after injury, as mentioned 
before (Li et al., 2008). However, it is not known whether single high dose of caffeine 
(150 mg/kg) can mediate adaptation of adenosine receptors on cerebral vascular 
smooth muscle resulting in favorable CBF changes following TBI, as observed in case 
of chronic caffeine. To conclude, although acute caffeine treated rats reached a 
normalization in CBF by 3 days and 7 days post-TBI, acute reduction (~27%) in CBF by 
4 hrs post-TBI may have worse effects on other secondary brain damage events. This 
supports the notion that chronic caffeine pretreatment is more beneficial in optimizing 
CBF changes following TBI, compared to acute caffeine pretreatment. 
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CHAPTER 6 TO ASSESS GROUP-WISE DIFFERENCES IN CEREBRAL BLOOD 
FLOW OF RATS FOLLOWING TBI WITH AND WITHOUT CAFFEINE (CHRONIC 
AND ACUTE) PRETREATMENT (Specific Aim 3) 
6.1 Introduction 
Although we have analyzed regional and global CBF changes following TBI across 
various time points within individual groups (specific aim 1 and 2), it is imperative to 
analyze group-wise differences in CBF following TBI at each time point for better 
understanding of the effects of caffeine (chronic and acute) pretreatment. Repeated 
measures of analysis of variance (ANOVA) is a commonly used statistical method for 
analyzing changes in mean values over three or more time points/treatment conditions 
within same subjects in each group, often termed as "mixed design". It is also referred 
to as ANOVA for correlated samples. Our analysis of repeated measures was based on 
the assumption that all the subjects (SD rats, male) used in different groups (sham, TBI 
only, CC+TBI, AC+TBI) of this study had similar levels of regional and global CBF 
before sham surgery or TBI (pre-scan). We have analyzed the group-wise differences in 
CBF under different treatment conditions (sham surgery, TBI only, CC+TBI, AC+TBI) at 
each time point using repeated measures ANOVA. A schematic design of the time-
course repeated measures of CBF used for this study is shown below (Figure 6-1). 
Regional (Rt PCx, Lt PCx, Avg PCx, Rt St, Lt St, Avg St, Rt Hp, Lt Hp, Avg Hp, Th and 
Bs), combined regional and global CBF values obtained from ASL data as a part of 
specific aim 1 and specific aim 2 were utilized here to perform repeated measures of 
ANOVA (specific aim 3). Group-wise differences in CBF were investigated across 
various time points (pre-scan=1 day before sham surgery or TBI, 4hrs, 24 hrs, 3 days 
95 
 
 
and 7 days post-TBI) in different treatment groups (sham, TBI only, chronic and acute 
caffeine pretreated rats subjected to TBI). 
 
Figure 6-1: Schematic design of the repeated measures of ANOVA used in this study 
for analyzing group-wise differences in CBF at each time point. A1 to A6 represent CBF 
value of six sham rats, B1 to B6 represent CBF value of six TBI rats, C1 to C6 represent 
CBF value of six CC+TBI rats and D1 to D6 represent CBF value of six AC+TBI rats. 
However, the actual samples size of each group used in this study was different from 
what is shown here. 
 
6.2 Statistical Analysis 
All data were analyzed for statistical significance using SPSS (version 20, Chicago, IL). 
The data were first tested for reliability by Cronbach's alpha test (Table 10). The CBF 
value obtained from ASL images was expressed as the mean value ± standard error of 
the mean (SEM). Group-wise differences in CBF at each time point were analyzed by 
repeated measures of analysis of variance (ANOVA). A p value of <0.05 was 
considered as significant. 
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6.3 Results (Group-wise Differences in CBF) 
Group-wise differences in the CBF of right parietal cortex (Rt PCx) across time 
In the Rt PCx of different groups, no apparent changes in CBF were observed until 7 
days post-TBI (Figure 41). At 4 hrs post-TBI rats from all four groups showed an 
insignificant reduction in the CBF of Rt PCx, compared to their pre-TBI levels. However, 
by 7 days post-TBI nearly significant reduction (p=0.07) in CBF was observed in TBI 
rats compared to sham rats.  However, CBF in TBI rats at 7 days post-TBI decreased 
significantly when compared to its pre-scan levels. 
 
Figure 6-2: Plot showing group-wise differences in CBF of the right parietal cortex (Rt 
PCx) at various time points (pre-scan=1 day before sham surgery/TBI, 4 hrs, 24 hrs, 3 
days and 7 days post-TBI) in sham rats, TBI only and chronic and acute caffeine 
pretreated rats subjected to TBI. No significant group-wise differences were observed. 
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Group-wise differences in the CBF of left parietal cortex (Lt PCx) across time 
Similar to Rt PCx, CBF of the Lt PCx also did not show any significant changes between 
groups until 7 days post-TBI. Lt PCx from all four groups showed an insignificant 
reduction in the CBF at 4 hrs post-TBI, compared to their pre-scan levels (Figure 6-3). 
By 7 days post-TBI, the reduction in Lt PCx CBF of TBI rats was close to significance in 
comparison to sham and chronic caffeine pretreated rats. 
 
Figure 6-3: Plot showing group-wise differences in CBF of the left parietal cortex (Lt 
PCx) at various time points (pre-scan=1 day before sham surgery/TBI, 4 hrs, 24 hrs, 3 
days and 7 days post-TBI) in sham rats, TBI only and chronic and acute caffeine 
pretreated rats subjected to TBI. 
 
Group-wise differences in CBF of the average of right and left parietal cortex (Avg 
PCx) across time 
Similar to Rt and Lt PCx, CBF in the average of Rt and Lt PCx (Avg PCx) showed no 
apparent changes in CBF until 3 days post-TBI (Figure 6-4). But, by 7 days post-TBI, 
CBF in the Avg PCx of TBI rats showed significant reduction compared to sham rats 
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(p=0.049) and with an insignificant reduction compared to chronic caffeine treated rats 
(p=0.09). No other significant changes in CBF between the groups were observed. 
 
Figure 6-4: Plot showing group-wise differences in CBF of average of the right and left 
parietal cortex (Avg PCx) at various time points (pre-scan=1 day before sham 
surgery/TBI, 4 hrs, 24 hrs, 3 days and 7 days post-TBI) in sham rats, TBI only and 
chronic and acute caffeine pretreated rats subjected to TBI. Asterisk indicates 
significant difference (p<0.05). 
 
 
Group-wise differences in the CBF of right  striatum (Rt St) across time 
CBF in the Rt St of rats from all four groups did not exhibit any significant changes at 
pre-TBI, 24 hrs, 3 days and 7 days post-TBI (Figure 6-5). But, a significant reduction 
(p=0.030) in the CBF of Rt St of acute caffeine treated was observed at 4hrs post-TBI, 
when compared to TBI rats. However, 7 days after trauma, a nearly significant reduction 
(p=0.055) in CBF of Rt St from TBI rats was observed when compared to sham rats. 
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Figure 6-5: Plot showing group-wise differences in CBF of the right striatum (Rt St) at 
various time points (pre-scan=1 day before sham surgery/TBI, 4 hrs, 24 hrs, 3 days and 
7 days post-TBI) in sham rats, TBI only and chronic and acute caffeine pretreated rats 
subjected to TBI. Asterisk indicates significant difference (p<0.05). 
 
 
Group-wise differences in the CBF of left  striatum (Lt St) across time 
Similar to Rt St, CBF in Lt St also did not show any significant differences between 
groups before TBI, 24 hrs and 3 days following TBI (Figure 6-6). But, significant 
changes were observed at 4 hrs and 7 days post-TBI. In acute caffeine pretreated rats, 
CBF in the Lt St at 4 hrs post-TBI was found to be significantly reduced compared to 
sham, TBI only, and chronic caffeine pretreated rats (p=0.026, 0.002 and 0.012 
respectively). Additionally, at 7 days post-TBI CBF in the Lt St of TBI rats was 
significantly decreased compared to  sham, chronic and acute caffeine pretreated rats 
(p=0.007, 0.016 and 0.004 respectively). However, by 7 days-post TBI, this decrease 
appears to be normalized. On the other hand, by 7 days post-TBI in the case of rats 
100 
 
 
subjected to TBI, CBF in the Lt St significantly reduced in comparison to sham, CC+TBI 
and AC+TBI. 
 
Figure 6-6: Plot showing group-wise differences in CBF of the left striatum (Lt St) at 
various time points (pre-scan=1 day before sham surgery/TBI, 4 hrs, 24 hrs, 3 days and 
7 days post-TBI) in sham rats, TBI only and chronic and acute caffeine pretreated rats 
subjected to TBI. Asterisks indicate significant difference (p<0.05). 
 
 
Group-wise differences in CBF of the average of right and left striatum (Avg St) 
across time 
Unlike CBF in other regions (PCx, St, Th, Bs), Avg St alone showed significant 
differences in CBF between groups following TBI, as well as  before TBI CBF (Figure 6-
7). Pre-TBI CBF level in the Avg St of acute caffeine treated rats showed significant 
reduction (p=0.037) compared to TBI only group. At 4 hrs post-TBI, CBF of Avg St in the 
acute caffeine treated rats (AC+TBI) was significantly reduced compared to sham 
(p=0.037), TBI (p=0.006) and CC+TBI rats (p=0.031). In addition, CBF of Avg St in 
AC+TBI rats decreased significantly (p=0.046) by 24 hrs post-TBI, compared to TBI rats 
101 
 
 
that showed a trend of recovery by 3 and 7 days post-TBI. After 7 days following TBI, 
the CBF of the Avg St from TBI rats showed a significant reduction when compared to 
sham, chronic and acute (p=0.009, 0.018 and 0.001 respectively) caffeine pretreated 
rats. 
 
Figure 6-7: Plot showing group-wise differences in CBF of the average of right and left 
striatum (Avg St) at various time points (pre-scan=1 day before sham surgery/TBI, 4 
hrs, 24 hrs, 3 days and 7 days post-TBI) in sham rats, TBI only and chronic and acute 
caffeine pretreated rats subjected to TBI. Asterisks indicate significant difference 
(p<0.05). 
 
 
Group-wise differences in the CBF of right hippocampus (Rt Hp) across time 
Similar to Rt PCx, CBF in the Rt Hp in all four different groups did not show any 
significant changes at any time points (Figure 6-8).  
102 
 
 
 
Figure 6-8: Plot showing group-wise differences in CBF of the right hippocampus (Rt 
Hp) at various time points (pre-scan=1 day before sham surgery/TBI, 4 hrs, 24 hrs, 3 
days and 7 days post-TBI) in sham rats, TBI only and chronic and acute caffeine 
pretreated rats subjected to TBI. No significant group-wise differences were observed. 
 
 
Group-wise differences in the CBF of left hippocampus (Lt Hp) across time 
No apparent changes in CBF of Lt Hp were observed before-TBI (pre-scan), 24 hrs and 
3 days post-TBI (Figure 6-9). However, significant changes (p<0.05) in the CBF of Lt Hp 
were observed 4 hrs and 7 days post-TBI. By 4 hrs post-TBI, CBF in the Lt Hp of acute 
caffeine pretreated rats was significantly reduced when compared to sham (p=0.037), 
chronic  caffeine pretreated rats (p=0.023) and nearly significant reduction (p=0.059) 
compared to TBI rats. Additionally, by 7 days post-TBI, CBF of the Lt Hp in TBI rats was 
significantly reduced when compared to sham, CC+TBI and AC+TBI rats (p=0.019, 
0.039 and 0.042 respectively). 
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Figure 6-9: Plot showing group-wise differences in CBF of the left hippocampus (Lt Hp) 
at various time points (pre-scan=1 day before sham surgery/TBI, 4 hrs, 24 hrs, 3 days 
and 7 days post-TBI) in sham rats, TBI only and chronic and acute caffeine pretreated 
rats subjected to TBI. Asterisks indicate significant difference (p<0.05). 
 
 
Group-wise differences in CBF of the average of right and left hippocampus (Avg 
Hp) across time 
Similar to CBF in the Rt Hp and Lt Hp, the average of Rt and Lt Hp (Avg Hp) did not 
show any significant changes before TBI, and 24 hrs and 3 days following TBI (Figure 
6-10). But, CBF of the Avg Hp in acute caffeine pretreated rats at 4 hrs post-TBI was 
significantly reduced when compared to sham (p=0.047), CC+TBI rats (p=0.027) and 
nearly significant reduction (p=0.057) was observed when compared with TBI rats. 
Furthermore, by 7 days post-TBI, the CBF of Avg Hp in TBI rats was significantly 
reduced compared to sham (p=0.028), TBI rats (p=0.039) and almost significantly 
reduced compared to AC+TBI rats (p=0.050). 
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Figure 6-10: Plot showing group-wise differences in CBF of the average of right and left 
hippocampus (Avg Hp) at various time points (pre-scan=1 day before sham surgery/TBI, 
4 hrs, 24 hrs, 3 days and 7 days post-TBI) in sham rats, TBI only and chronic and acute 
caffeine pretreated rats subjected to TBI. Asterisks indicate significant difference 
(p<0.05). 
 
 
Group-wise differences in the CBF of thalamus (Th) across time 
Unlike other PCx, St, Hp, CBF the thalamus did not show any significant group-wise 
differences at any time point pre and post-trauma (Figure 6-11). 
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Figure 6-11: Plot showing group-wise differences in the CBF of the thalamus (Th) at 
various time points (pre-scan=1 day before sham surgery/TBI, 4 hrs, 24 hrs, 3 days and 
7 days post-TBI) in sham rats, TBI only and chronic and acute caffeine pretreated rats 
subjected to TBI. No significant group-wise differences were observed. 
 
Group-wise differences in the CBF of brainstem (Bs) across time 
Similar to thalamus, CBF in the brainstem did not show any significant group-wise 
differences at any time point before and after TBI (Figure 6-12).   
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Figure 6-12: Plot showing group-wise differences in the CBF of the brainstem (Bs) at 
various time points (pre-scan=1 day before sham surgery/TBI, 4 hrs, 24 hrs, 3 days and 
7 days post-TBI) in sham rats, TBI only and chronic and acute caffeine pretreated rats 
subjected to TBI. No significant group-wise differences were observed. 
 
Group-wise differences in the combined regional CBF (rCBF) across time 
Combined regional CBF (average of the CBF in Rt PCx, Lt PCx, Rt St, Lt St, Rt Hp, Lt 
Hp, Th and Bs) showed no significant group-wise differences before TBI and 24 hrs 
after TBI (Figure 6-13). But, at 4 hrs post-TBI, the combined rCBF of the acute caffeine 
pretreated rats was significantly reduced compared to sham (p=0.021) and TBI rats 
(p=0.006). Also, by 3 days post-TBI, the combined rCBF of the chronic caffeine 
pretreated rats was significantly reduced (p=0.040) compared to TBI rats. Furthermore, 
it was observed that the combined rCBF of TBI rats at 7 days post-TBI was significantly 
reduced when compared to sham (p=0.002), CC+TBI (p=0.005) and AC+TBI rats 
(p=0.001). 
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Figure 6-13: Plot showing group-wise differences in the combined regional CBF at 
various time points (pre-scan=1 day before sham surgery/TBI, 4 hrs, 24 hrs, 3 days and 
7 days post-TBI) in sham rats, TBI only and chronic and acute caffeine pretreated rats 
subjected to TBI. Asterisks indicate significant difference (p<0.05). 
 
Group-wise differences in the global CBF across time 
Global CBF did not show any apparent group wise differences before TBI, 24 hrs and 3 
days following TBI (Figure 6-14). Similar to combined rCBF, group-wise differences in 
global CBF also showed significant differences (p<0.05) by 4 hrs and 7 days post-TBI. 
At 4 hrs post-TBI, the global CBF in the acute caffeine pretreated rats was significantly 
reduced compared to sham, TBI, and chronic caffeine pretreated rats (p=0.001, 0.013 
and 0.002). But AC+TBI showed a temporal pattern of recovery by 24 hrs and 3 days 
post-TBI. However, global CBF in the TBI rats at 7 days post-TBI showed significant 
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reduction in comparisons with sham (p=0.007) and chronic caffeine pretreated rats 
(p=0.002). No other significant group-wise differences were found. 
 
Figure 6-14: Plot showing group-wise differences in the global CBF at various time 
points (pre-scan=1 day before sham surgery/TBI, 4 hrs, 24 hrs, 3 days and 7 days post-
TBI) in sham rats, TBI only and chronic and acute caffeine pretreated rats subjected to 
TBI. Asterisks indicate significant difference (p<0.05). 
 
 
6.4 Discussion (Specific Aim 3) 
Using repeated measures of ANOVA, at each MRI scanning time point, our study has 
statistically analyzed group-wise differences in the CBF between the four groups of rats: 
sham, TBI only, CC+TBI (chronic caffeine pretreated rats subjected to TBI) and AC+TBI 
(acute caffeine pretreated rats subjected to TBI). 
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Pre-scan time point: No significant group-wise differences in regional and global 
CBF before TBI 
Rats from all four groups underwent MRI scanning 1 day before sham surgery or TBI. 
CBF measured in various brain regions (Rt PCx, Lt PCx, Rt St, Lt St, Rt Hp, Lt Hp, Th 
and Bs) did not exhibit any apparent changes. However, pre-TBI CBF level of the 
average in Lt and Rt St in AC+TBI rats was found to be significantly different (p=0.037) 
compared to TBI group rats. CBF in none of the other regions and also global CBF, did 
not show any significant differences when compared between different groups (sham, 
TBI, CC+TBI and AC+TBI) at pre-scan level. This clearly indicates that, both regional 
and global CBF levels in rats from different groups were similar before TBI. Any 
respective changes in CBF following TBI, can be attributed to resulting from trauma (TBI 
rats) and the treatment (CC+TBI and AC+TBI) they have received.  
 
4 hrs post-TBI: Acute caffeine pretreated rats subjected to TBI exhibited 
significant reductions in regional and global CBF  
In general, CBF changes following TBI were most affected at 4 hrs post-TBI and 7 days 
post-TBI as observed in one-way ANOVA analysis of CBF changes in TBI only rats. 
Similarly, analysis of group-wise differences using repeated measures ANOVA also 
showed significant changes in regional and global CBF between different  groups at 4 
hrs post-TBI. Lt PCx, Rt PCx and average of Lt and Rt PCx (Avg PCx) did not show any 
significant changes in CBF between groups at 4 hrs post-TBI. But AC+TBI rats showed 
significant reduction in CBF of Rt St compared to TBI rats. Similarly Lt St and Avg St of 
AC+TBI rats showed significant reductions in CBF compared to sham, TBI and CC+TBI 
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rats. This clearly indicates that CBF of the striatum in the AC+TBI rats worsened at 4 
hrs following TBI. Similarly, CBF in the Lt HP and Avg Hp of AC+TBI was significantly 
lower compared to sham and TBI rats. But thalamus and brainstem did not show any 
significant differences in CBF between groups at 4 hrs post-TBI. Both combined rCBF 
and global CBF reflected the changes observed in CBF of the striatum and 
hippocampus. At 4 hrs post-TBI, combined regional and global CBF in the AC+TBI was 
significantly reduced compared to sham and TBI rats. Furthermore, global CBF in 
AC+TBI rats was significantly reduced compared to CC+TBI rats. To summarize, acute 
caffeine pretreated rats subjected to TBI showed significantly reduced regional (Rt St, Lt 
St, Avg St, Lt Hp and Avg Hp) and global CBF compared to the rest of the groups. 
Sham, TBI and CC+TBI rats did not show any significant changes in CBF at 4 hrs post-
TBI. This clearly indicates the role of vasoconstriction (decreased CBF) mediated by 
acute caffeine at 4 hrs post-TBI. Implications of this acute reduction in CBF by 4 hrs 
following TBI was already discussed in Chapter 5 (section 5.5.3). 
 
24 hrs post-TBI: No apparent group-wise differences in regional and global CBF 
From Chapters 4 and 5, it is observed that both regional and global CBF in the rats that 
underwent TBI (TBI, CC+TBI and AC+TBI rats) showed a trend of recovery in CBF by 
24 hrs post-TBI. Although, AC+TBI rats showed significant reductions in CBF compared 
to other groups at 4 hrs post-TBI, this group showed recovery by 24 hrs post-TBI. 
Similarly, repeated measures of ANOVA also did not show any group-wise differences 
in CBF of the brain regions (Rt PCx, Lt PCx, Rt St, Lt St, Rt Hp, Lt Hp, Th and Bs). 
However, CBF of the Avg St alone in the AC+TBI rats was significantly reduced 
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compared to TBI rats by 24 hrs post-TBI. No other group-wise differences in regional or 
global CBF were observed at 24 hrs post-TBI. This indicates that cerebral 
hypoperfusion observed at 4 hrs post-TBI in AC+TBI did not last until 24 hrs post-TBI 
and that vasoconstrictive effects mediated by acute caffeine were not exhibited 24 hrs 
post-TBI. Furthermore, both combined rCBF and global CBF at 24 hrs post-TBI did not 
show any significant group-wise differences, indicating the existence of similar levels of 
CBF in all four groups. 
 
3 days post-TBI: No significant group-wise differences in regional and global CBF 
Similar to 24 hrs post-TBI, group-wise differences in regional and global CBF by 3 days 
post-TBI did not show any significant changes. The CBF in different regions of the brain 
(Rt PCx, Lt PCx, Rt St, Lt St, Rt Hp, Lt Hp, Th and Bs) and global CBF at 3 days post-
TBI did not any show significant changes when compared between the four groups. 
Although CBF in various cortical (Rt PCx, Lt PCx) and sub-cortical regions (Rt St, Lt St, 
Rt Hp, Lt Hp) of the CC+TBI rats showed insignificant reduction when compared to TBI 
rats, only combined rCBF showed a significant reduction when compared to TBI rats. 
This indicates that no apparent reductions in CBF were observed between different 
groups at 3 days post-TBI.  
 
7 days post-TBI: Rats subjected to TBI without chronic or acute caffeine 
pretreatment exhibited significant reductions in both  regional and global CBF 
As discussed earlier in Chapter 4 (section 4.5.3), both regional and global CBF in TBI 
rats was found to be significantly reduced at 7 days post-TBI when compared to their 
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pre-TBI levels within the group by one-way ANOVA. Similarly, group-wise differences 
analyzed at 7 days post-TBI using repeated measures of ANOVA also revealed that 
both regional and global CBF of the TBI rats was significantly reduced when compared 
to sham rats. An apparent decrease in CBF of cortical (Lt, Rt and Avg PCx) and sub-
cortical regions (Lt St, Avg St, Lt Hp and Avg Hp) at 7 days post-TBI was observed, 
when compared to sham and CC+TBI rats. However, thalamus and brainstem regions 
did not show any group-wise differences in CBF at 7 days following TBI and also at 
other time points. Both combined rCBF and global CBF of TBI rats at 7 days post-TBI 
also showed significant reductions compared to sham and chronic caffeine pretreated 
rats. In general, regional and global CBF of chronic and acute caffeine pretreated rats at 
7 days post-TBI was similar to sham rat CBF levels. This clearly indicates that only TBI 
group rats have shown decreased CBF levels at 7 days post-TBI when compared to 
rats from the other three groups (sham, CC+TBI and AC+TBI). This reduction in CBF in 
TBI rats at 7 days post-TBI may be attributed to post-traumatic events (impaired 
cerebral autoregulation, changes in cerebral vasculature, etc) leading to secondary 
brain damage. From this we can infer that chronic and acute caffeine pretreatment can 
potentially restore the CBF at 7 days following trauma. 
 
To summarize, no apparent group-wise changes in CBF were observed before TBI, 24 
hrs and 3 days following TBI. Although TBI rats showed slightly decreased global CBF 
at 4 hrs post-TBI compared to sham rats, only acute caffeine pretreated rats showed a 
significant reduction in regional and global CBF compared to sham, TBI and CC+TBI 
groups at 4hrs post-TBI. This significant decrease in CBF of AC+TBI rats at 4 hrs post-
TBI may be attributed to vasoconstrictive effects of acute caffeine pretreatment 30 
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minutes before TBI. Similar to AC+TBI rats at 4 hrs post-TBI, TBI rats at 7 days post-
TBI showed significant reduction in regional and global CBF when compared to sham, 
CC+TBI and AC+TBI. Although, AC+TBI rats could show recovery in CBF by 7 days 
post-TBI, its acute reduction in CBF at 4 hrs post-TBI may worsen the effects on the 
secondary brain damage as discussed earlier in Chapter 4 (section 4.5.3). Among the 
rats that underwent TBI (TBI, CC+TBI and AC+TBI rats), only chronic caffeine 
pretreated rats maintained CBF throughout without any apparent changes when 
compared with TBI and AC+TBI rats. Therefore, it supports our hypothesis that chronic 
caffeine pretreatment may be beneficial in optimizing CBF changes following TBI, 
compared to acute caffeine pretreatment. 
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CHAPTER 7 CONCLUSIONS AND FUTURE WORK 
There have only been limited studies on cerebral blood flow (CBF) changes following a 
closed head injury in an experimental animal model. The few available experimental 
studies have reported only acute CBF changes (up to 48 hrs post-TBI) following TBI 
with CBF measurements from only one or two cerebral regions. None of the previous 
experimental studies have reported sub-acute (up to 7 days post-TBI) changes in CBF 
in an animal model of closed head injury. Work performed as part of this thesis offers 
evidence related to CBF changes during acute and sub-acute periods from various 
brain regions following a traumatic insult. These findings are listed below under section 
7.1. 
7.1 Conclusions 
Surface righting (SR) duration following TBI 
 Rats subjected to TBI using the Marmarou impact acceleration device (2 m height, 
450 g weight) demonstrated significantly prolonged SR duration (an indirect 
measure of duration of loss consciousness) compared to rats that underwent sham 
surgery. This prolonged SR duration can be attributed to the traumatic insult.   
 Acute caffeine (150 mg/kg) pretreated rats subjected to TBI (AC+TBI) also 
demonstrated significantly increased SR duration compared to sham rats. Therefore, 
it is reasoned that acute caffeine treatment 30 minutes before TBI was not able to 
mitigate the prolonged SR duration that was demonstrated by TBI-only rats. 
 Unlike TBI and AC+TBI rats, on the other hand, chronic caffeine (1.5 g/L) pretreated 
rats subjected to TBI (CC+TBI) did not show any marked increase in SR duration 
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compared to sham rats. This reduced SR duration following TBI is attributed to the 
effects of chronic caffeine pretreatment. Considering that duration of loss of 
consciousness following TBI is used as a measure in grading the severity of injury, 
our study suggests that chronic caffeine can potentially alleviate the SR duration (i.e. 
reduce the SR duration) compared to TBI-only rats and in turn decrease the injury 
severity. 
 To the best of our knowledge, this is the first study to report differences in SR 
duration immediately after TBI in rats that underwent caffeine (acute and chronic) 
pretreatment. 
 
Cerebral blood flow changes in sham rats 
 In sham rats, using ASL perfusion imaging, we demonstrated no significant changes 
in regional (Rt PCx, Lt PCx, Avg PCx, Rt St, Lt St, Avg St, Rt Hp, Lt Hp, Avg Hp, Th 
and Bs) CBF following 21 days of pure-water treatment.  
 Furthermore, no apparent changes in regional and global CBF were observed at 4 
hrs, 24 hrs, 3 days and 7 days post-sham surgery. 
 It can be postulated that a close relationship exists between regional and global 
CBF, as both of them showed similar trends across various time points.  
 Therefore, sham rats served as an ideal control to compare the effects of chronic 
caffeine treatment on CBF before TBI and also for comparing post-traumatic CBF 
changes in all rats that underwent TBI. 
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Cerebral blood flow changes in rats subjected to TBI without caffeine treatment 
 Our study showed significant changes in global and regional CBF following TBI 
induced by the Marmarou impact acceleration device (2 m height, 450 g weight). 
 In thalamus and brainstem, no apparent changes in CBF following TBI were 
observed throughout the study period 
 CBF in cortical (Rt PCx, Lt PCx and  Avg PCx) and sub-cortical (Rt St, Lt St, Avg St, 
Rt Hp, Lt Hp and Avg Hp) regions was affected the most following TBI. They showed 
up to 19% reduction in CBF at 4 hrs post-TBI and ~49% reduction at 7 days post-TBI 
compared to their pre-TBI levels. Similarly, combined rCBF showed a 16% reduction 
at 4hrs post-TBI and ~44% reduction by 7 days post-TBI. Furthermore, global CBF 
also showed slight reduction (20%) at 4 hrs post-TBI and significant reduction 
(~32%) by 7 days post-TBI. No apparent changes in CBF were observed at 24 hrs 
and 3 days following TBI. These findings indicate CBF changes as early as 4 hours 
after TBI and may continue to evolve until 7 days despite signs of normalization at 
24 hrs and 3 days post TBI.   
 Decreased CBF changes during the acute and sub-acute periods following TBI may 
even reach ischemic or sub-ischemic levels and may potentially trigger secondary 
injury events. This underscores the need for optimal clinical interventions well 
beyond the traumatic insult.   
 Therefore, it is strongly recommended to routinely measure CBF changes in the 
critical care management of TBI patients to alleviate possible secondary brain 
damage. 
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 These findings indicate a potential need to develop potential therapeutic agents 
which can offer neuroprotection by modulating CBF following TBI.  
 To the best of our knowledge, our study is the first to extensively measure both 
regional (Rt PCx, Lt PCx, Avg PCx, Rt St, Lt St, Avg St, Rt Hp, Lt Hp, Avg Hp, Th 
and Bs) and global CBF changes up to 7 days in an animal model of closed head 
injury induced by the Marmarou impact acceleration device. 
 
Cerebral blood flow changes in chronic caffeine pretreated rats subjected to TBI  
 Data from our study suggest the development of tolerance to vasoconstrictive effects 
of caffeine (1.5g/L) following 21 days of caffeinated water treatment in rats as 
evidenced by regional and global CBF levels before and after chronic caffeine 
treatment.    
 This study also supports our hypothesis that chronic caffeine treatment for 21 days 
before TBI can potentially help in restoration of the TBI-induced CBF reductions. 
 Similar to sham and TBI rats, CBF in thalamus and brainstem of CC+TBI rats also 
did not show any significant changes. 
 Unlike TBI rats, CBF in the cortical (Rt PCx, Lt PCx and  Avg PCx) and sub-cortical 
(Rt St, Lt St, Avg St, Rt Hp, Lt Hp and Avg Hp) regions of CC+TBI rats did not show 
any reduction by 7 days post-TBI.  
 In addition, both combined rCBF and global CBF did not show any apparent 
changes in CBF following TBI in CC+TBI rats. 
 Therefore, it is suggested that chronic caffeine pretreatment can potentially optimize 
CBF following TBI. This optimization has been postulated to be related to adenosine 
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receptor mediated changes on cerebrovascular smooth muscle, various brain 
regions or due to withdrawal effects (increased CBF) of chronic caffeine.  
 To the best of our knowledge, ours is the first study to demonstrate chronic caffeine 
mediated CBF changes in rats subjected to a closed head injury in an experimental 
model of TBI in rats. 
 
Cerebral blood flow changes in acute caffeine pretreated rats subjected to TBI  
 In accordance with previous studies, our study demonstrated putative 
vasoconstrictive effects of caffeine (150 mg/kg) upon acute intake. 
 Unlike sham, TBI and CC+TBI rats, significant reductions in CBF of the thalamus 
and brainstem were observed, compared to pre-TBI levels. This may suggest the 
negative effects of acute caffeine on CBF following TBI. 
 In the case of TBI rats, acute reduction (19%) in CBF in the cortical (PCx) and sub-
cortical (St, Hp and Th) regions by 4 hrs post-TBI was observed. But in the case of 
AC+TBI rats, this CBF reduction was exacerbated (decreased by 27%) by 4 hrs 
post-TBI. Furthermore, unlike TBI rats, global CBF in AC+TBI rats was significantly 
reduced at 4hrs post-TBI compared to its pre-TBI levels. This marked reduction in 
both regional and global CBF by 4 hrs post-TBI in acute caffeine pretreated rats can 
be attributed to the combined effect of TBI and vasoconstrictive effects of acute 
caffeine.  
 Acute reduction (4 hrs post-TBI) in CBF following TBI plus acute caffeine 
pretreatment (150 mg/kg) leading to vasoconstriction may exacerbate reduction in 
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CBF following TBI and may even reach ischemic or sub-ischemic levels  potentially 
worsening the outcome. This is an area requiring further study. 
 
7.2 Future Work 
Our study has demonstrated CBF changes following closed head injury up to 7 days 
post-TBI. But, ischemic cell death or ischemia mediated cell changes following TBI were 
not studied. Association between cerebral hypoperfusion and traumatic axonal injury 
(TAI) as well as neuronal cell injury needs to be studied, TAI is commonly observed 
sequel of  TBI. Our study also demonstrated effects of repeated doses of chronic 
caffeine (1.5 g/L) and also a single dose of acute caffeine (150 mg/kg) on CBF changes 
following TBI. However, further studies are required to determine if these CBF changes 
are neuroprotective and helped reduced secondary injury changes. These can include 
behavioral, histological and biomarker studies. CSF samples from the rats in this study 
as well as fixed brains from these rats have been saved for such studies in the near 
future, as discussed below. Furthermore, the effects of other doses of chronic and acute 
caffeine on CBF following TBI need to be tested.  
 
In this study, several other MRI sequences (T1 and T2 imaging, Susceptibility Weighted 
Imaging-SWI, Diffusion Tensor Imaging-DTI, Magnetic Resonance Spectroscopy-MRS) 
data were collected along with ASL data for future analysis. These data sets can be 
used to better understand the secondary axotomy of TBI and also effects of caffeine in 
offering neuroprotection against TBI. T1 and T2 images can be used to study structural 
or inflammatory changes following TBI. SWI data can provide information on oxygen 
saturation levels and micro hemorrhages. Changes in DTI parameters (FA - fractional 
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anisotropy, AD  - axial diffusivity, RD – radial diffusivity, ADC - apparent diffusion 
coefficient) provide crucial information on axonal injury progression following TBI.  
Furthermore, MRS imaging data can be used to do quantitative analysis of changes in 
neurometabolites (N-acetylaspartate (NAA), creatine/phosphocreatine (Cr), choline 
containing compounds (Cho), lactate, etc) in vivo and to explore metabolic and 
biochemical changes in TBI; thus helping in prognosis of the outcome. Correlative 
studies between ASL and these MRI data sets can help in attaining a better 
understanding of TBI pathology and effects of caffeine treatment.  
 
In addition to MRI data, biological samples (CSF, serum and brain tissue) have been 
collected from all the rats used in this study. It is planned to perform 
immunohistochemical and biomarker studies on these samples to better establish the 
effects of caffeine mediated CBF changes following TBI. Neuroprotective effects of 
caffeine (chronic & acute) can be tested by performing biomarker studies (e.g. ELISA or 
Western blotting) on CSF and serum samples. Effects of caffeine on inflammation 
following TBI can be studied using CSF and serum samples with antibodies, including 
IL-1, TNF-α and others. By determining caffeine concentration in CSF and serum 
following TBI using high pressure liquid chromatography (HPLC), its correlation to TBI 
outcome can be studied. Furthermore, histological assessment of inflammatory cell 
infiltration in brain (using standard immunofluorescence immunohistochemistry) with 
CD45 antibody (marker of inflammatory cells) can provide vital information regarding 
occurrence of inflammation following TBI and effects of caffeine pretreatment on 
inflammation following TBI can be better understood. Also, histological assessment of 
impaired axonal transport using β-APP and RMO-14 immunostaining and detection of 
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apoptotic cells by TUNEL staining can be done. These studies, independently and 
collectively, can provide crucial information in understanding and establishing the 
potential neuroprotective effects of caffeine in relation to TBI. 
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APPENDIX A 
 
Glossary of Acronyms and Abbreviations 
 
ABP - Arterial blood pressure 
AC+TBI - Acute caffeine pretreated rats subjected to TBI 
Ade - Adenosine 
ADP - Adenosine diphosphate 
AIS - Abbreviated injury severity 
ANOVA - Analysis of variance 
ASL - Arterial spin labeling 
ATP - Adenosine triphosphate 
Avg Hp - Average of left and right hippocampus 
Avg PCx - Average of left and right parietal cortex 
Avg St - Average of left and right striatum 
BBB - Blood-brain-barrier 
Bs - Brainstem 
CASL - Continuous arterial spin labeling 
cAMP - Cyclic adenosine monophosphate 
CBF - Cerebral blood flow 
CBV - Cerebral blood volume 
CC+TBI - Chronic caffeine pretreated rats subjected to TBI 
CDC - Centers for Disease Control and Prevention 
CHI - Closed head injury 
CNS - Central nervous system 
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CPA - Cerebral pressure autoregulation 
CPP - Cerebral perfusion pressure 
CVP - Cerebral venous pressure 
CVSM - Cerebrovascular smooth muscle 
DAI - Diffuse axonal injury 
DTI - Diffusion tensor Imaging 
EC50 - Half maximal effective concentration value 
FoV - Field of view 
g - grams 
gCBF - Global cerebral blood flow 
GPCR - G protein coupled receptor 
GCS - Glasgow coma scale 
ICP - Intracranial pressure 
Lt Hp - Left hippocampus 
Lt PCx - Left parietal cortex 
Lt St - Left striatum 
LDF - Laser-Doppler flowmetry 
LD50 - Median lethal dose 
LOC - Loss of consciousness 
LSD - Least significant difference 
m - meters 
MABP - Mean arterial blood pressure 
min - Minutes 
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MRI - Magnetic resonance imaging 
 
MRS - Magnetic resonance spectroscopy 
NO - Nitric oxide 
OHI - Open head injury 
 
PASL - Pulsed arterial spin labeling 
PET - Positron emission tomography 
PTA - Posttraumatic amnesia 
rCBF - Regional cerebral blood flow 
RF - Radio frequency 
ROI - Region of interest 
RT - Repetition time 
Rt Hp - Right hippocampus 
Rt PCx - Right parietal cortex 
Rt St - Right striatum 
sec - Seconds 
SEM - Standard error of the mean 
SMC - Smooth muscle cell 
SNR - Signal-to-noise ratio 
SPECT - Single photon emission computed tomography 
SR - Surface righting 
STDEV - Standard deviation 
SWI - Susceptibility weighted imaging 
TA - Time of acquisition 
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TAI - Traumatic axonal injury 
TBI - Traumatic brain injury 
TE - Echo time 
Th - Bilateral thalamus 
VSM - Vascular smooth muscle 
XeCT - Xenon-enhanced computed tomography 
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APPENDIX B 
Analysis of combined regional CBF (rCBF) by taking size of the cerebral regions 
into account. 
Previously (Chapters 4, 5 & 6), combined rCBF of each rat at each time point was 
calculated by taking the simple average of the CBF values from all the regions where 
CBF was measured (Rt PCx, Lt PCx, Rt St, Lt St, Rt Hp, Lt Hp, Th and Bs). The size 
(number of pixels in ASL image) of the each region was not taken into account. Here, 
the combined rCBF was calculated by taking the number of pixels in each region into 
account. The number of pixels in the ASL image for each region represents the size of 
the corresponding region. The formula below demonstrates the combined rCBF 
calculation used here. 
 
Where, A, B, C,.... represent the different cerebral regions from where CBF was 
measured. 
 
Combined regional CBF changes in sham group rats 
Combined rCBF levels of the sham group rats calculated by taking size of cerebral 
regions into account remained at the same pre and post pure-water treatment (Figure 
B1). However, a significant decrease (23%) was observed at 24 hrs post-sham surgery 
and with a trend towards recovery by 3 days post-sham surgery. But, no significant 
changes in combined rCBF of sham group rats were found when the size of the cerebral 
regions (number of pixels in ASL image) was not included in combined rCBF calculation 
(Figure 4-14). 
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Figure B1: Plot showing changes in combined regional CBF (rCBF) of sham rats at 
various time points (pre-Rx=pre-water treatment, pre-scan=1 day before sham surgery, 
4 hrs, 24 hrs, 3 days and 7 days post-sham surgery). Asterisk indicates significant 
difference (p<0.05) in combined rCBF at 24 hrs post-TBI compared to its pre-water 
treatment (pre-Rx) level. 
 
Combined regional CBF changes in TBI-only group rats 
In rats subjected to TBI, combined rCBF calculated by taking the size of cerebral 
regions into account showed a significant reduction (36%) by 7 days post-TBI compared 
to their pre-TBI level, as well as to their 24 hrs post-TBI and 3 days post-TBI levels 
(Figure B2). Although a slight reduction in combined rCBF was observed at 4 hrs post-
TBI, it was not found to be significant. Combined rCBF of TBI rats calculated without 
taking the size of cerebral regions into account also showed a similar trend with a 
significant reduction by 7 days post-TBI compared to their pre-TBI level, as well as to 
their 24 hrs post-TBI and 3 days post-TBI levels (Figure 4-19). Also, global CBF in TBI 
rats showed a similar trend. 
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Figure B2: Plot showing changes in combined regional CBF (rCBF) in rats subjected to 
TBI. CBF was measured at various time points: pre-scan=1 day before TBI,  4 hrs, 24 
hrs, 3 days and 7 days post-TBI. Asterisk indicates significant difference (p<0.05) in 
combined rCBF at 7 days post-TBI compared to its pre-TBI, 24 hrs and 3 days post-TBI. 
 
Combined regional CBF changes in CC+TBI group rats 
Combined rCBF of CC+TBI rats calculated by taking the size of cerebral regions into 
account showed a significant reduction (25%) by 4 hrs post-TBI compared to its pre-
caffeine treatment levels and then a trend of recovery by 24 hrs and 3 days post-TBI 
(Figure B3). But, combined rCBF calculated without taking size of cerebral regions into 
account did not show any significant changes across the time points, when compared to 
its pre-caffeine treatment levels (Figure 5-6). 
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Figure B3: Plot showing changes in combined regional CBF (rCBF) in chronic caffeine 
pretreated rats at various time points: pre-Rx=pre-caffeine treatment 21 days before 
TBI, pre-scan=1 day before TBI, 4 hrs, 24 hrs, 3 days and 7 days post-TBI. Asterisk 
indicates significant difference (p<0.05) in combined rCBF at 4 hrs post-TBI compared 
to pre-caffeine treatment and 7 days post-TBI levels. 
 
Combined regional CBF changes in AC+TBI group rats 
Combined rCBF of AC+TBI rats calculated by taking size of cerebral regions into 
account showed a significant reduction (32%) by 4 hrs post-TBI compared to its pre-TBI 
and 7 days post-TBI levels (Figure B4). Combined rCBF calculated without taking size 
of cerebral regions into account also showed a significant decrease by 4 hrs post-TBI 
compared to its 7 days post-TBI level (Figure 5-11). 
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Figure B4: Plot showing changes in combined regional CBF (rCBF) in acute caffeine 
pretreated rats at various time points:  pre-scan=1 day before TBI, 4 hrs, 24 hrs, 3 days 
and 7 days post-TBI. Asterisk indicates significant difference (p<0.05) in combined rCBF 
at 4 hrs post-TBI compared to its pre-TBI and 7 days post-TBI levels. 
 
In general, combined rCBF calculated by taking the size of cerebral regions into account 
showed trends similar to combined rCBF calculated without considering the size of 
cerebral regions. The differences which resulted between the two combined rCBF 
calculation methods are: 1) Sham group rats showed significant decrease by 24 hrs 
post-sham surgery compared to pretreatment levels. 2) CC+TBI rats showed significant 
decrease by 4 hrs post-TBI compared to its pre-caffeine treatment levels. 
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APPENDIX C 
Tables representing mean, standard deviation and percentage (%) change in CBF 
compared to the pre-Rx or pre-scan levels of rats in different groups. 
 
CBF measurements from sham group rats: 
Sham group - Right Parietal Cortex CBF 
Rat ID Pre-Rx Pre-scan 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 229 157 
 
359 177 329 
Rat 2 535 286 282 439 290 357 
Rat 3 559 448 220 322 153 347 
Rat 4 364 343 
  
393 282 
Rat 5 283 308 
 
160 594 437 
Rat 6 333 574 252 202 395 464 
Rat 7 434 431 353 254 443 413 
Average 391 364 277 289 349 376 
STDEV 124 134 57 104 155 65 
SEM 47 51 28 42 59 24 
% Change 0 -6.9 -29.2 -26.0 -10.7 -3.9 
 
 
 
 
Sham group - Left Parietal Cortex CBF 
Rat ID Pre-Rx Pre-scan 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 189 267 273 366 266 309 
Rat 2 467 262 261 367 229 286 
Rat 3 479 353 221 292 219 313 
Rat 4 345 354 214 
 
403 315 
Rat 5 239 300 
 
163 
 
392 
Rat 6 328 563 286 183 400 463 
Rat 7 389 340 338 233 370 350 
Average 348 348 266 267 315 347 
STDEV 108 102 46 89 86 62 
SEM 41 39 19 36 35 23 
% Change 0 0.1 -23.7 -23.2 -9.6 -0.3 
 
 
 
 
Sham group - Average of right and left parietal Cortex CBF 
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Rat ID Pre-Rx Pre-scan 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 209 212 273 363 221 319 
Rat 2 501 274 271 403 260 322 
Rat 3 519 400 220 307 186 330 
Rat 4 354 348 214 
 
398 298 
Rat 5 261 304 
 
161 594 415 
Rat 6 331 569 269 192 398 464 
Rat 7 411 386 345 243 406 381 
Average 369 356 265 278 352 361 
STDEV 116 114 47 96 141 61 
SEM 44 43 19 39 53 23 
% Change 0 -3.6 -28.2 -24.7 -4.8 -2.2 
 
 
Sham group - Right striatum CBF 
Rat ID Pre-Rx Pre-scan 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 294 
 
352 436 233 429 
Rat 2 561 365 424 415 167 328 
Rat 3 661 
 
333 447 151 341 
Rat 4 354 412 
  
448 393 
Rat 5 345 361 
 
252 521 426 
Rat 6 384 541 
 
203 485 577 
Rat 7 493 509 402 236 475 588 
Average 442 438 378 332 354 440 
STDEV 134 83 42 112 163 105 
SEM 51 37 21 46 62 40 
% Change 0 -0.9 -14.5 -25.0 -19.8 -0.3 
 
 
Sham group - Left striatum CBF 
Rat ID Pre-Rx Pre-scan 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 331 227 445 495 260 442 
Rat 2 474 343 
 
383 318 349 
Rat 3 646 
 
377 466 213 374 
Rat 4 403 424 
  
462 420 
Rat 5 364 337 
 
239 535 420 
Rat 6 398 560 
  
487 550 
Rat 7 481 522 409 237 471 551 
Average 442 402 410 364 392 444 
STDEV 105 125 34 122 126 79 
SEM 40 51 20 55 48 30 
% Change 0 -9.1 -7.3 -17.7 -11.3 0.3 
Sham group - Average of right and left striatum CBF 
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Rat ID Pre-Rx Pre-scan 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 313 227 399 466 247 436 
Rat 2 518 354 424 399 243 339 
Rat 3 654 
 
355 457 182 358 
Rat 4 379 418 
  
455 407 
Rat 5 355 349 
 
246 528 423 
Rat 6 391 551 
 
203 486 564 
Rat 7 487 516 406 237 473 570 
Average 442 403 396 335 373 442 
STDEV 118 119 29 119 143 92 
SEM 45 49 15 49 54 35 
% Change 0 -9 -10.5 -24.4 -15.6 0 
 
Sham group - Right hippocampus CBF 
Rat ID Pre-Rx Pre-scan 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1  173 297 327 170 292 
Rat 2 384 271 356 360 360 318 
Rat 3 342 371 228 293 365 383 
Rat 4 367 383 
  
373 313 
Rat 5 365 325 
   
388 
Rat 6  440 279 226 420 395 
Rat 7 299 331 321 211 361 400 
Average 351 328 296 283 342 356 
STDEV 33 86 48 64 87 46 
SEM 15 33 21 29 36 17 
% Change 0 -6.7 -15.7 -19.4 -2.8 1.2 
 
 
Sham group - Left hippocampus CBF 
Rat ID Pre-Rx Pre-scan 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 230 249 315 386 248 338 
Rat 2 433 380 303 450 444 
 Rat 3 346 347 280 346 290 411 
Rat 4 379 343 
  
393 320 
Rat 5 320 298 
   
410 
Rat 6  469 307 233 383 398 
Rat 7 322 377 354 235 426 395 
Average 338 352 312 330 364 379 
STDEV 68 69 27 95 78 39 
SEM 28 26 12 43 32 16 
% Change 0 4 -7.8 -2.5 7.6 11.9 
 
Sham group - Average of right and left hippocampus CBF 
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Rat ID Pre-Rx Pre-scan 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 230 211 306 357 209 315 
Rat 2 409 326 330 405 402 318 
Rat 3 344 359 254 320 328 397 
Rat 4 373 363 
  
383 317 
Rat 5 343 312 
   
399 
Rat 6  455 293 230 402 397 
Rat 7 311 354 338 223 394 398 
Average 335 340 304 307 353 363 
STDEV 61 73 33 79 76 43 
SEM 25 28 15 36 31 16 
% Change 0 1.5 -9.2 -8.4 5.4 8.4 
 
 
Sham group - Thalamus CBF 
Rat ID Pre-Rx Pre-scan 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1  351 578 541 368 515 
Rat 2 691 416 571 543 494 503 
Rat 3 604 571 328 452 388 498 
Rat 4 440 577 345 
 
569 448 
Rat 5 281 464 270 323 
 
483 
Rat 6 508 749 
 
310 580 682 
Rat 7 474 466 496 322 464 492 
Average 500 513 431 415 477 517 
STDEV 141 131 134 111 89 76 
SEM 58 50 55 45 36 29 
% Change 0 2.8 -13.7 -16.9 -4.5 3.5 
 
 
Sham group - Brainstem CBF 
Rat ID Pre-Rx Pre-scan 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 564 600 545 626 537 580 
Rat 2 737 431 493 748 444 602 
Rat 3 718 524 
 
842 567 547 
Rat 4 717 671 689 590 
 
658 
Rat 5 645 735 532 646 944 696 
Rat 6 741 788 792 654 
 
680 
Rat 7 708 748 617 601 
 
693 
Average 690 642 611 672 623 637 
STDEV 64 131 113 91 220 60 
SEM 24 49 46 34 110 23 
% Change 0 -6.9 -11.4 -2.5 -9.7 -7.7 
Sham group - Combined regional CBF 
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Rat ID Pre-Rx Pre-scan 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 288 267 378 429 267 391 
Rat 2 519 337 372 447 332 372 
Rat 3 534 422 282 413 277 391 
Rat 4 407 421 366 590 428 379 
Rat 5 346 372 401 274 619 444 
Rat 6 427 569 354 264 444 512 
Rat 7 437 453 398 276 428 476 
Average 422 406 364 385 399 424 
STDEV 88 95 40 121 122 54 
SEM 33 36 15 46 46 21 
% Change 0 -3.9 -13.8 -9 -5.5 0.3 
 
Sham group - Global CBF 
Rat ID Pre-Rx Pre-scan 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 390 410 423 494 369 392 
Rat 2 559 381 435 580 388 481 
Rat 3 517 490 
 
535 375 439 
Rat 4 476 539 452 409 561 502 
Rat 5 442 495 449 543 582 508 
Rat 6 510 602 505 384 577 490 
Rat 7 586 574 477 425 463 612 
Average 497 499 457 481 474 489 
STDEV 67 81 30 76 98 68 
SEM 25 31 12 29 37 26 
% Change 0 0.3 -8.1 -3.2 -4.7 1.6 
 
 
CBF measurements from TBI-only group rats: 
TBI-only group - Right parietal cortex CBF 
Rat ID Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 254 304 175 596 157 
Rat 2 450 307 239 326 419 
Rat 3 298 363 452 189 256 
Rat 4 529 221 347 484 169 
Rat 5 502 434 557 490 201 
Rat 6 539 379 562 
 
202 
Average 429 335 389 417 234 
STDEV 123 74 163 160 97 
SEM 50 30 66 71 40 
% Change 0 -21.9 -9.3 -2.7 -45.4 
TBI-only group - Left parietal cortex CBF 
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Rat ID Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 276 290 245 438 191 
Rat 2 402 272 330 336 387 
Rat 3 270 345 379 154 222 
Rat 4 541 191 301 471 134 
Rat 5 515 411 560 567 226 
Rat 6 486 
 
585 
 
207 
Average 415 302 400 393 228 
STDEV 120 82 141 157 85 
SEM 49 37 57 70 35 
% Change 0 -27.3 -3.6 -5.3 -45.1 
 
TBI-only group - Average of right and left parietal cortex CBF 
Rat ID Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 265 297 210 517 174 
Rat 2 426 290 285 331 403 
Rat 3 284 354 416 171 239 
Rat 4 535 206 324 478 152 
Rat 5 508 423 559 528 213 
Rat 6 512 379 573 
 
205 
Average 422 325 395 405 231 
STDEV 120 77 149 153 90 
SEM 49 31 61 68 37 
% Change 0 -23 -6.4 -4 -45.2 
 
TBI-only group - Right striatum CBF 
Rat ID Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 386 494 231 605 216 
Rat 2 451 555 353 430 416 
Rat 3 488 462 466 164 250 
Rat 4 624 238 457 577 182 
Rat 5 695 555 601 539 215 
Rat 6 670 462 670 679 159 
Average 552 461 463 499 240 
STDEV 128 117 160 183 92 
SEM 52 48 65 75 38 
% Change 0 -16.5 19.3 -9.7 -56.6 
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TBI-only group - Left striatum CBF 
Rat ID Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 426 450 268 463 172 
Rat 2 546 496 423 434 416 
Rat 3 484 415 435 190 231 
Rat 4 650 248 467 549 
 Rat 5 724 617 674 533 239 
Rat 6 661 501 662 706 191 
Average 582 455 488 479 250 
STDEV 115 122 155 170 97 
SEM 47 50 63 70 43 
% Change 0 -21.9 -16.1 -17.6 -57.1 
 
TBI-only group - Average of right and left striatum CBF 
Rat ID Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 406 472 250 534 194 
Rat 2 499 526 388 432 416 
Rat 3 486 439 451 177 241 
Rat 4 637 243 462 563 182 
Rat 5 710 586 638 536 227 
Rat 6 666 482 666 693 175 
Average 567 458 476 489 239 
STDEV 120 117 156 174 90 
SEM 49 48 64 71 37 
% Change 0 -19.3 -16.1 -13.8 -57.8 
 
TBI-only group - Right hippocampus CBF 
Rat ID Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 286 300 202 398 192 
Rat 2 423 
 
402 363 306 
Rat 3 340 317 262 180 284 
Rat 4 426 
 
283 
 
133 
Rat 5 403 
  
394 144 
Rat 6 
  
418 
 
182 
Average 376 309 313 334 207 
STDEV 61 12 93 104 72 
SEM 27 9 42 52 29 
% Change 0 -17.9 -16.6 -11.1 -44.9 
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TBI-only group - Left hippocampus CBF 
Rat ID Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 279 306 195 348 181 
Rat 2 368 
 
403 353 324 
Rat 3 345 310 253 141 285 
Rat 4 440 
 
313 
 
123 
Rat 5 403 
  
466 188 
Rat 6 436 
 
420 
 
174 
Average 379 308 317 327 213 
STDEV 61 3 96 135 76 
SEM 25 2 43 68 31 
% Change 0 -18.6 -16.3 -13.6 -43.9 
 
TBI-only group - Average of left and right hippocampus CBF 
Rat ID Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 283 303 199 373 187 
Rat 2 396 
 
403 358 315 
Rat 3 343 314 258 161 285 
Rat 4 433 
 
298 
 
128 
Rat 5 403 
  
430 166 
Rat 6 436 
 
419 
 
178 
Average 382 309 315 331 210 
STDEV 59 8 94 117 73 
SEM 24 6 42 59 30 
% Change 0 -19.3 -17.5 -13.6 -45.1 
 
TBI-only group - Thalamus CBF 
Rat ID Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 384 352 283 537 253 
Rat 2 454 410 524 425 585 
Rat 3 425 417 514 251 283 
Rat 4 663 
 
522 
 
242 
Rat 5 
   
652 
 Rat 6 
  
588 
 
258 
Average 482 393 486 466 324 
STDEV 124 36 117 171 147 
SEM 62 21 53 85 66 
% Change 0 -18.4 1.0 -3.2 -32.7 
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TBI-only group - Brainstem CBF 
Rat ID Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 638 553 721 
 
546 
Rat 2 554 
 
491 768 673 
Rat 3 509 435 718 446 521 
Rat 4 596 526 673 483 476 
Rat 5 624 546 
 
496 695 
Rat 6 685 
  
483 676 
Average 601 515 651 535 598 
STDEV 63 55 109 131 94 
SEM 26 27 54 59 39 
% Change 0 -14.3 8.3 -10.9 -0.5 
 
TBI-only group - Combined regional CBF 
Rat ID Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 353 375 271 481 224 
Rat 2 452 408 386 414 424 
Rat 3 388 379 419 202 282 
Rat 4 552 268 404 515 192 
Rat 5 549 510 598 512 251 
Rat 6 566 441 556 640 237 
Average 477 397 439 461 268 
STDEV 92 81 120 146 82 
SEM 38 33 49 60 33 
% Change 0 -16.8 -7.9 -3.3 -43.7 
 
TBI-only group - Global CBF 
Rat ID Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 429 411 402 636 283 
Rat 2 436 461 458 559 437 
Rat 3 396 359 513 271 331 
Rat 4 578 288 442 472 276 
Rat 5 629 469 675 512 341 
Rat 6 592 454 669 
 
392 
Average 510 407 527 490 343 
STDEV 101 71 118 137 62 
SEM 41 29 48 61 25 
% Change 0 -20.2 3.2 -3.9 -32.7 
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CBF measurements in chronic caffeine pretreated rats subjected to TBI: 
CC+TBI group - Right parietal cortex CBF 
Rat ID Pre-Rx Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 314 283 328 
 
258 444 
Rat 2 366 
  
502 562 397 
Rat 3 290 269 249 388 375 255 
Rat 4 298 561 260 402 205 461 
Rat 5 282 
 
375 240 233 432 
Rat 6 335 426 256 268 
 
348 
Average 314 385 294 360 327 390 
STDEV 32 137 56 107 147 77 
SEM 13 69 25 48 66 31 
% Change 0 22.5 -6.5 14.6 4.0 24 
 
 
 
CC+TBI group - Left parietal cortex CBF 
Rat ID Pre-Rx Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 326 310 276 
 
287 476 
Rat 2 343 
  
490 453 355 
Rat 3 265 278 219 311 338 308 
Rat 4 280 582 285 439 204 465 
Rat 5 317 
 
368 263 209 411 
Rat 6 370 366 249 249 212 307 
Average 317 384 279 350 284 387 
STDEV 39 137 56 108 99 75 
SEM 16 68 25 48 40 31 
% Change 0 21.2 -11.8 10.6 -10.4 22.1 
 
 
 
CC+TBI group - Average of right and left parietal cortex CBF 
Rat ID Pre-Rx Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 320 296 302 
 
273 460 
Rat 2 355 
  
496 507 376 
Rat 3 278 273 234 350 356 282 
Rat 4 289 571 272 420 205 463 
Rat 5 299 
 
371 252 221 422 
Rat 6 353 396 253 258 212 327 
Average 316 384 286 355 296 388 
STDEV 33 136 54 105 118 74 
SEM 13 68 24 47 48 30 
% Change 0 21.2 -9.6 12.1 -6.7 22.6 
141 
 
 
CC+TBI group - Right striatum CBF 
Rat ID Pre-Rx Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 303 357 297 451 
 
545 
Rat 2 362 
  
638 424 506 
Rat 3  230 325 528 369 436 
Rat 4 393 535 518 438 
 
447 
Rat 5 389 
 
687 397 213 474 
Rat 6 364 603 420 354 
 
365 
Average 362 431 449 468 335 462 
STDEV 36 170 159 102 109 62 
SEM 16 85 71 42 63 25 
% Change 0 36.1 41.8 47.6 5.8 45.9 
 
 
CC+TBI group - Left striatum CBF 
Rat ID Pre-Rx Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 317 366 293 539 
 
607 
Rat 2 393 
  
688 459 499 
Rat 3  325 372 501 352 410 
Rat 4 378 512 546 466 229 511 
Rat 5 422 
 
684 385 241 485 
Rat 6 373 588 452 358 
 
338 
Average 377 448 469 490 320 475 
STDEV 38 123 152 119 108 92 
SEM 17 62 68 49 54 38 
% Change 0 18.9 24.6 30.0 -15.0 26.1 
 
CC+TBI group - Average of right and left striatum CBF 
Rat ID Pre-Rx Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 310 362 295 495 
 
576 
Rat 2 378 
  
663 442 503 
Rat 3  278 349 515 361 423 
Rat 4 386 524 532 452 229 479 
Rat 5 406 
 
686 391 227 480 
Rat 6 369 596 436 356 
 
352 
Average 370 440 460 479 315 469 
STDEV 36 146 155 109 105 76 
SEM 16 73 69 44 53 31 
% Change 0 19.0 24.3 29.4 -14.9 26.8 
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CC+TBI group - Right hippocampus CBF 
Rat ID Pre-Rx Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 272 226 281 323 237 
 Rat 2 314 364 
  
300 413 
Rat 3  
 
282 343 223 203 
Rat 4 361 423 339 286 194 404 
Rat 5 269 
   
256 
 Rat 6 292 363 363 297 
 
337 
Average 302 344 316 312 242 339 
STDEV 38 84 41 26 40 97 
SEM 17 42 21 13 18 48 
% Change 0 14.1 4.9 3.5 -19.8 12.5 
 
 
 
CC+TBI group - Left hippocampus CBF 
Rat ID Pre-Rx Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 287 233 236 331 262 
 Rat 2 356 414 
  
332 412 
Rat 3  
 
282 365 248 229 
Rat 4 360 455 358 351 217 409 
Rat 5 312 
   
277 
 Rat 6 296 290 404 290 
 
314 
Average 322 348 320 334 267 341 
STDEV 34 104 75 33 42 87 
SEM 15 52 38 16 19 44 
% Change 0 8.0 -0.7 3.7 -17.1 5.8 
 
 
 
CC+TBI group - Average of right and left hippocampus CBF 
Rat ID Pre-Rx Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 280 230 259 327 250 
 Rat 2 335 389 
  
316 413 
Rat 3  
 
282 354 236 216 
Rat 4 361 439 349 319 206 407 
Rat 5 291 
   
267 
 Rat 6 294 327 384 294 
 
326 
Average 312 346 319 324 255 341 
STDEV 34 90 58 25 41 92 
SEM 15 45 29 12 18 46 
% Change 0 10.9 2.0 3.6 -18.3 9.1 
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CC+TBI group - Thalamus CBF 
Rat ID Pre-Rx Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 343 314 
   
598 
Rat 2 437 
   
664 612 
Rat 3  395 
  
521 414 
Rat 4 450 563 423 373 281 
 Rat 5  
   
322 
 Rat 6 409 
 
431 342 237 516 
Average 410 424 427 358 405 535 
STDEV 48 127 6 22 181 91 
SEM 24 73 4 16 81 46 
% Change 0 3.5 4.2 -12.8 -1.2 30.6 
 
 
 
CC+TBI group - Brainstem CBF 
Rat ID Pre-Rx Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 812 613 
 
569 678 449 
Rat 2 781 647 
 
673 847 446 
Rat 3 705 731 321 469 438 538 
Rat 4 631 604 643 594 628 778 
Rat 5 537 
 
690 
 
476 796 
Rat 6 526 705 709 
 
404 685 
Average 665 660 591 576 579 615 
STDEV 121 56 182 84 170 159 
SEM 50 25 91 42 70 65 
% Change 0 -0.8 -11.2 -13.4 -13.1 -7.5 
 
 
 
CC+TBI group - Combined regional CBF 
Rat ID Pre-Rx Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 353 326 285 434 321 519 
Rat 2 402 454 
 
593 482 448 
Rat 3 385 347 292 412 347 338 
Rat 4 381 524 411 413 260 482 
Rat 5 352 
 
552 321 267 500 
Rat 6 362 466 396 307 266 383 
Average 372 424 387 413 324 445 
STDEV 20 84 109 102 85 71 
SEM 8 38 49 42 35 29 
% Change 0 13.7 4.0 11.0 -13.0 19.5 
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CC+TBI group - Global CBF 
Rat ID Pre-Rx 
Pre-
TBI 
4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 612 424 462 422 468 577 
Rat 2 534 
  
697 624 508 
Rat 3 463 506 339 534 477 410 
Rat 4 445 562 488 538 338 630 
Rat 5 433 
 
583 364 328 592 
Rat 6 437 598 523 358 425 594 
Average 487 523 479 486 443 552 
STDEV 72 76 90 130 109 80 
SEM 29 38 40 53 44 33 
% Change 0 7.2 -1.7 -0.4 -9.0 13.2 
 
CBF measurements in acute caffeine pretreated rats subjected to TBI: 
AC+TBI group - Right parietal cortex CBF 
Rat ID Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 
 
291 442 
 
595 
Rat 2 450 417 447 
 
393 
Rat 3 277 117 244 284 524 
Rat 4 202 185 
 
345 341 
Rat 5 263 200 
 
328 663 
Rat 6 341 313 419 113 338 
Rat 7 439 377 470 776 197 
Average 329 268 395 369 409 
STDEV 100 109 91 245 164 
SEM 41 41 41 110 62 
% Change 0 -18.4 20.2 12.3 24.5 
 
AC+TBI group - Left parietal cortex CBF 
Rat ID Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 
 
282 429 
 
576 
Rat 2 418 306 
  
327 
Rat 3 249 158 211 294 371 
Rat 4 219 235 
 
326 308 
Rat 5 262 183 
 
259 460 
Rat 6 296 264 406 175 308 
Rat 7 442 361 460 717 221 
Average 314 251 359 354 333 
STDEV 93 70 113 210 117 
SEM 38 27 56 94 44 
% Change 0 -20.1 14.2 12.7 5.8 
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AC+TBI group - Average of left and right parietal cortex CBF 
Rat ID Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 
 
287 435 
 
586 
Rat 2 434 362 447 
 
360 
Rat 3 263 138 228 289 448 
Rat 4 211 210 
 
335 324 
Rat 5 262 192 
 
293 562 
Rat 6 319 289 412 144 323 
Rat 7 440 369 465 747 209 
Average 322 260 388 362 371 
STDEV 96 87 97 227 137 
SEM 39 33 43 102 52 
% Change 0 -19.1 20.7 12.5 15.4 
 
 
AC+TBI group - Right striatum CBF 
Rat ID Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 446 462 393 
 
677 
Rat 2 458 431 371 
 
389 
Rat 3 266 182 162 405 
 Rat 4 
 
136 
 
508 466 
Rat 5 266 278 
 
436 726 
Rat 6 480 133 455 246 457 
Rat 7 579 485 426 
 
207 
Average 410 274 354 399 449 
STDEV 125 156 116 111 191 
SEM 51 59 52 55 78 
% Change 0 -33.1 -13.7 -2.7 9.6 
 
 
AC+TBI group - Left striatum CBF 
Rat ID Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 423 444 369 
 
606 
Rat 2 484 386 514 
 
410 
Rat 3 310 272 149 420 544 
Rat 4 
 
222 
 
467 431 
Rat 5 271 265 71 405 501 
Rat 6 477 201 465 252 432 
Rat 7 637 451 505 
 
229 
Average 436 300 341 386 425 
STDEV 132 105 191 93 120 
SEM 54 40 78 47 45 
% Change 0 -31.3 -21.8 -11.4 -2.6 
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AC+TBI group - Average of right and left striatum CBF 
Rat ID Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 435 453 381 
 
642 
Rat 2 471 409 443 
 
400 
Rat 3 288 227 156 413 544 
Rat 4 
 
179 
 
488 449 
Rat 5 269 272 71 421 614 
Rat 6 479 167 460 249 445 
Rat 7 608 468 466 
 
218 
Average 423 287 319 393 445 
STDEV 128 130 172 102 144 
SEM 52 49 70 51 55 
% Change 0 -32.2 -24.5 -7.2 5.2 
 
 
AC+TBI group - Right hippocampus CBF 
Rat ID Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 387 
  
396 
 Rat 2 367 338 365 
 
356 
Rat 3 274 
  
318 351 
Rat 4 
   
431 243 
Rat 5 224 154 
 
381 530 
Rat 6 391 212 259 253 388 
Rat 7 392 
 
243 
 
209 
Average 330 235 289 346 346 
STDEV 72 94 66 71 114 
SEM 29 54 38 32 47 
% Change 0 -28.8 -12.3 4.9 5.0 
 
 
AC+TBI group - Left hippocampus CBF 
Rat ID Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 393 
  
442 
 Rat 2 368 326 368 
 
386 
Rat 3 344 
  
370 384 
Rat 4 
   
351 351 
Rat 5 214 170 
 
347 449 
Rat 6 371 223 323 371 400 
Rat 7 367 
 
298 
 
197 
Average 333 240 330 360 361 
STDEV 65 79 35 38 87 
SEM 27 46 20 17 35 
% Change 0 -28 -0.9 8.1 8.5 
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AC+TBI group - Average of right and left hippocampus CBF 
Rat ID Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 390 
  
419 
 Rat 2 368 332 367 
 
371 
Rat 3 309 
  
344 368 
Rat 4 
   
391 297 
Rat 5 219 162 
 
364 490 
Rat 6 381 218 291 312 394 
Rat 7 380 
 
271 
 
203 
Average 331 237 310 353 354 
STDEV 67 87 51 41 97 
SEM 27 50 29 18 39 
% Change 0 -28.4 -6.6 6.4 6.8 
 
 
AC+TBI group - Thalamus CBF 
Rat ID Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 496 
 
386 
  Rat 2 434 
 
381 
 
423 
Rat 3 458 
  
592 491 
Rat 4 
   
564 395 
Rat 5 304 
  
482 660 
Rat 6 581 226 536 453 474 
Rat 7 561 422 411 
 
331 
Average 468 324 443 523 462 
STDEV 100 139 73 66 113 
SEM 41 98 36 33 46 
% Change 0 -30.7 -5.3 11.8 -1.1 
 
 
AC+TBI group - Brainstem CBF 
Rat ID Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 607 581 671 
  Rat 2 577 556 718 
 
717 
Rat 3 518 
  
511 582 
Rat 4 562 
 
574 580 733 
Rat 5 547 
 
576 428 643 
Rat 6 534 276 668 513 761 
Rat 7 621 476 579 751 683 
Average 560 436 623 557 687 
STDEV 38 138 62 121 66 
SEM 14 69 26 54 27 
% Change 0 -22.1 11.3 -0.6 22.6 
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AC+TBI group - Combined regional CBF 
Rat ID Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 447 400 438 419 614 
Rat 2 439 386 442 
 
412 
Rat 3 323 182 192 385 461 
Rat 4 299 195 574 435 394 
Rat 5 
 
208 239 377 573 
Rat 6 423 229 427 280 429 
Rat 7 497 426 418 748 264 
Average 396 271 382 445 422 
STDEV 77 109 131 160 117 
SEM 31 41 50 65 44 
% Change 0 -31.5 -3.6 12.4 6.6 
 
 
AC+TBI group - Global CBF 
Rat ID Pre-TBI 4 hrs-post 24 hrs-post 3 days-post 7 days-post 
Rat 1 550 456 508 
  Rat 2 489 447 550 
 
425 
Rat 3 385 262 
 
434 464 
Rat 4 440 236 323 455 408 
Rat 5 351 225 377 387 579 
Rat 6 472 249 481 421 445 
Rat 7 492 388 422 595 284 
Average 438 301 431 458 434 
STDEV 68 103 85 80 95 
SEM 26 39 35 36 39 
% Change 0 -31.3 -1.7 4.6 0.9 
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APPENDIX D 
Tables showing the sample size (n) for CBF measurements in each region at their 
corresponding time point for rats in all four different groups: 
Sham Group:  
Sample size (n) for CBF measurements in each region at each time point 
Cerebral 
Regions 
Pre-Rx Pre-scan 
4 hrs-
post 
24 hrs-
post 
3 days-
post 
7 days-
post 
Rt Pcx 7 7 4 6 7 7 
Lt Pcx 7 7 6 6 6 7 
Avg PCx 7 7 6 6 7 7 
Rt St 7 5 4 6 7 7 
Lt St 7 6 3 5 7 7 
Avg St 7 6 4 6 7 7 
Rt Hp 5 7 5 5 6 7 
Lt Hp 6 7 5 5 6 6 
Avg Hp 6 7 5 5 6 7 
Th 6 7 6 6 6 7 
Bs 7 7 6 7 4 7 
Combined 
rCBF 
7 7 7 7 7 7 
Global CBF 7 7 6 7 7 7 
 
TBI-only Group: 
Sample size (n) for CBF measurements in each region at each time point 
Cerebral Regions Pre-scan 
4 hrs-
post 
24 hrs-
post 
3 days-
post 
7 days-
post 
Rt Pcx 6 6 6 5 6 
Lt Pcx 6 5 6 5 6 
Avg PCx 6 6 6 5 6 
Rt St 6 6 6 6 6 
Lt St 6 6 6 6 5 
Avg St 6 6 6 6 6 
Rt Hp 5 2 5 4 6 
Lt Hp 6 2 5 4 6 
Avg Hp 6 2 5 4 6 
Th 4 3 5 4 5 
Bs 6 4 4 5 6 
Combined rCBF 6 6 6 6 6 
Global CBF 6 6 6 5 6 
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CC+TBI Group: 
Sample size (n) for CBF measurements in each region at each time point 
Cerebral 
Regions 
Pre-Rx Pre-scan 
4 hrs-
post 
24 hrs-
post 
3 days-
post 
7 days-
post 
Rt Pcx 6 4 5 5 5 6 
Lt Pcx 6 4 5 5 6 6 
Avg PCx 6 4 5 5 6 6 
Rt St 5 4 5 6 3 6 
Lt St 5 4 5 6 4 6 
Avg St 5 4 5 6 4 6 
Rt Hp 5 4 4 4 5 4 
Lt Hp 5 4 4 4 5 4 
Avg Hp 5 4 4 4 5 4 
Th 4 3 2 2 5 4 
Bs 6 5 4 4 6 6 
Combined 
rCBF 6 5 5 6 6 6 
Global 
CBF 6 4 5 6 6 6 
 
AC+TBI Group: 
Sample size (n) for CBF measurements in each region at each time point 
Cerebral 
Regions 
Pre-scan 
4 hrs-
post 
24 hrs-
post 
3 days-
post 
7 days-
post 
Rt Pcx 6 7 5 5 7 
Lt Pcx 6 7 4 5 7 
Avg PCx 6 7 5 5 7 
Rt St 6 7 5 4 6 
Lt St 6 7 6 4 7 
Avg St 6 7 6 4 7 
Rt Hp 6 3 3 5 6 
Lt Hp 6 3 3 5 6 
Avg Hp 6 3 3 5 6 
Th 6 2 4 4 6 
Bs 7 4 6 5 6 
Combined rCBF 6 7 7 6 7 
Global CBF 7 7 6 5 6 
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Traumatic brain injury (TBI) is a global health problem with significant socio-economic 
costs. Closed head TBIs are one of the major causes of physical disability and cognitive 
disorder in young adults and a leading cause of death in children. 
 
 Alteration in cerebral blood flow due to an impaired autoregulation is one of the 
most common consequences of TBI. However, studies related to understanding the 
temporal changes in cerebral blood flow (CBF) following TBI in experimental models are 
limited. The few available studies report acute reduction in CBF following TBI; 
knowledge related to CBF changes at sub-acute periods extending to 7 days after TBI is 
still not known. Furthermore, reduction in CBF has been associated with unfavorable 
neurological outcome and can render the brain vulnerable to secondary damage. 
However, interventions that can restore neuronal function after TBI are lacking. A few 
available studies have demonstrated that caffeine acts as a neuroprotectant in several 
neurological disorders acting through diverse mechanisms. It has been postulated that 
caffeine may offer neuroprotection by restoring or maintaining adequate CBF following 
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TBI. Thus, studying the CBF changes following TBI and its potential modulation by 
caffeine pretreatment forms the central theme of this research. 
 
 We investigated the CBF changes in male Sprague Dawley rats at 4hrs, 24 hrs, 3 
days and 7 days following closed head injury, with and without caffeine (chronic and 
acute) pretreatment. TBI was induced using the Marmarou impact acceleration device 
(2 m height, 450 g weight). Rats subjected to TBI showed reduced regional and global 
CBF at 4hrs and 7 days following TBI. In contrast, rats that underwent chronic caffeine  
pretreatment (1.5 g/L) for 3 weeks did not show apparent changes in regional and 
global CBF following TBI, indicating a potential benefit after TBI. Acute caffeine 
treatment (150 mg/kg, i.p. injection 30 minutes before TBI) showed significant 
reductions in CBF at 4 hrs post-TBI, further deteriorating the cerebral perfusion. 
 
 In addition, chronic caffeine pretreated rats demonstrated significantly reduced 
surface righting duration following TBI, compared to acute caffeine treated rats 
subjected to TBI and rats subjected to TBI without caffeine treatment. Therefore, 
chronic caffeine treatment may be beneficial in offering a degree of neuroprotection 
against TBI. This study was able to support the hypothesis that chronic caffeine can 
restore or optimize CBF following TBI and this optimization may be related to the 
adaptation of adenosine receptors on vascular smooth muscle cells. This may form the 
stepping stone for further studies on beneficial effects of caffeine in TBI. 
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